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Abstract 
The Hippo signalling pathway is a conserved kinase cascade involved in 
the regulation of tissue growth and organ size. Activation of the Hippo 
pathway through multiple upstream inputs results in phosphorylation and 
inactivation of the transcriptional co-activator, Yes associated protein 
(Yap). While the role of Yap as an oncogene and an effector of the Hippo 
pathway is well established, its role in cellular differentiation is less well 
known. In this present work I have utilised quantitative 
immunofluorescence analysis to examine the expression of Yap in the 
differentiation of mouse embryonic stem cells (mESCs). I show that 
differentiation of mESCs is accompanied by an initial increase in nuclear 
Yap expression. Furthermore, I show that this increase in nuclear Yap 
expression is associated with differentiation towards the primitive 
endoderm lineage (PrE). Moreover, small molecule inhibition of Yap was 
able to decrease the proportion of cells differentiating towards PrE. 
Following on from these in vitro studies, I examine the expression of Yap 
in vivo in the corresponding differentiation event in mouse pre-
implantation embryos. I show that increased nuclear Yap expression is 
associated with expression of the PrE-specific transcription factor Gata6 
during specification and eventual sorting of the PrE. Culturing embryos in 
the presence of small molecule inhibitors of Yap resulted in decreased 
expression of Gata6 and a reduction in trophectoderm cell number. 
These studies demonstrate that Yap is involved in the process of cellular 
differentiation and is associated with specification of the PrE lineage. 
Finally I attempt to create an inducible knockout of Yap in mESCs using a 
serial targeting strategy, with the intention of creating a model system in 
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The Hippo pathway was first discovered in genetic mosaic screens of 
Drosophila in a search for mutations that resulted in tissue overgrowth. 
These screens revealed a kinase cascade comprising of Hippo kinase 
(Hpo), Warts kinase (Wts) and the scaffolding proteins Salvador (Sav) 
and Mob as tumour suppressor (Mats) (Harvey, Pfleger & Hariharan, 
2003; Justice et al., 1995; Xu et al., 1995; Tapon et al., 2002; Lai et al., 
2005). In this kinase cascade, the Hpo-Sav kinase complex 
phosphorylates and activates the Wts-Mats kinase complex (Wu et al., 
2003; Wei, Shimizu & Lai, 2007). The Wts-Mats kinase complex 
subsequently phosphorylates the transcriptional co-activator Yorkie (Yki) 
resulting in its retention in the cytoplasm (Figure 1.1) (Huang et al., 2005; 
Dong et al., 2007). When in the nucleus, Yki interacts with the 
transcription factor Scalloped, activating target genes associated with the 
promotion of proliferation and inhibition of apoptosis (Zhang et al., 2008). 
Deletion of Yki diminishes the overgrowth phenotype seen in Hpo, Wts 
and Sav mutants thus indicating Yki as the effector of Hippo signalling 
(Huang et al., 2005).   
Hippo	signalling	is	conserved	in	mammals		
The Hippo signalling pathway is highly conserved in mammals. The 
mammalian homologs of Hpo, Wts, Sav and Mats are Mammalian sterile 
like kinase 1/2 (Mst1/2), Large tumour suppressor homologue 1/2 
(Lats1/2), Salvador (Sav1) and Mob kinase activator 1A/B (Mob1/2), 
respectively (Callus, Verhagen & Vaux, 2006; Praskova, Xia & Avruch, 
2008; Chan et al., 2005). As in Drosophila, these proteins form a kinase 
cascade, which upon activation, phosphorylates and inactivates the 
mammalian homologs of Yki, Yes-associated protein (Yap) and Taz (also 
known as Wwtr1), preventing their interaction with the Scalloped 
homologs Tead1-4 (Figure 1.1) (Dong et al., 2007; Lei et al., 2008). The 
physiological relevance of the conservation of Hippo signalling was 
demonstrated by transgenic over expression of Yap in mice resulting in 
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an increase in size of the liver, ultimately leading to hepatocellular 
carcinoma (Dong et al., 2007; Camargo et al., 2007). These studies 
identified Yap as one of the main effectors of the Hippo pathway. 
 
Figure 1.1. Conservation of the Hippo kinase cascade in Drosophila and 
mammals. The corresponding proteins in Drosophila and mammals are 
represented in the same colours. In the nucleus Yki/Yap/Taz acts as a 
transcriptional co-activator, binding to Scalloped/Tead transcription factors and 
activating target gene expression. Upon activation of the Hippo kinase cascade 
Yki/Yap/Taz is phosphorylated and subsequently sequestered in the cytoplasm.  
Yes	associated	protein	(Yap)	
Yap was first identified in the chicken as a 65kDa protein, which interacts 
with the non-receptor tyrosine kinase c-Yes (Sudol, 1994). Anti-idiotypic 
antibodies were generated against the N-Terminal of the Yes protein in 
order to discover novel interacting proteins, leading to the discovery of 
Yap binding to c-Yes via an SH3 binding domain (Sudol, 1994). cDNA 
derived from chicken Yap was subsequently used as a probe to screen 
human and mouse cDNA libraries, leading to the discovery of human and 
mouse Yap (Sudol et al., 1995a). Analysis of the comparison between the 
analogous Yap proteins revealed a protein module containing two 
tryptophan residues, and was therefore named the WW domain (Sudol et 
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al., 1995b). WW domains mediate protein-protein binding via interaction 
with PPxY motifs.  
Structural analyses of Yap revealed subsequent protein interaction 
domains (Figure 1.2), including a coiled coil domain and a PDZ binding 
motif, allowing Yap to interact with proteins containing a PDZ domain 
(Mohler et al., 1999; Oka & Sudol, 2009). PDZ domains are ≈90 amino 
acid protein-interaction domains that are often found in trans-membrane 
or cytoskeletal associated proteins (Reviewed in Ye & Zhang, 2013). 
A transcriptional activation domain was mapped to the C-terminus of Yap, 
and fusion of Yap to the DNA binding domain of Gal4 is able to activate 
transcription at levels comparable to the potent transcriptional activator 
VP16 (Yagi et al., 1999). As Yap does not contain a DNA binding domain, 
it is recruited to DNA through association with transcription factors. Yap 
has been shown to interact, via WW its domains, with multiple DNA 
binding transcription factors, for example the Runt family member Runx2 
and the p53 family member p73 (Yagi et al., 1999; Strano, 2001). 
However, in an unbiased screen for target transcription factors of Yap, 
the Tead family of transcription factors were identified as the prominent 
target (Zhao et al., 2008). Yap interacts with Tead via a Tead-binding 
domain (Li et al., 2010). Furthermore, the cell growth and oncogenic 
properties of Yap were diminished upon knockdown of Tead, suggesting 
that Tead transcription factors are essential mediators of Hippo signalling. 
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Figure 1.2. Yap contains multiple regulatory domains. Schematic 
representing the known multiple interaction domains of Yap and residues 
targeted post-translational modification. The five serine residues phosphorylated 
by Lats are shown in yellow. The two serine residues phosphorylated by CK1 
are shown in lilac. The tyrosine residue phosphorylated by Src/Yes is shown in 
blue. The lysine residue targeted for methylation by Set7 is shown in red. TAD is 
Transcriptional activation domain. PDZ-BD is PDZ binding domain. (Figure 
adapted from Piccolo, Dupont & Cordenonsi, 2014). 
Regulation	of	Yap	activity	by	the	Hippo	pathway	
Yap can be directly phosphorylated on serine residues in five conserved 
HxRxxS motifs by the Hippo pathway kinase Lats (Figure 1.2). 
Phosphorylation of YAP S127 (Yap S112 in mouse) by Lats results in the 
generation of a 14-3-3 binding site (Figure 1.2) (Zhao et al., 2007; Hao et 
al., 2007). Subsequent binding of Yap to 14-3-3 proteins results in Yap 
being sequestered in the cytoplasm, thus unable to translocate to the 
nucleus to activate target gene expression (Zhao et al., 2007; Hao et al., 
2007). Phosphorylation of YAP S397 (Yap S381 in mouse) by Lats 
primes Yap for subsequent phosphorylation by Casein Kinase 1 (CK1), 
resulting in the generation of a ‘phosphodegron’, a motif that is 
recognised by β-transducin repeat-containing protein (β-TRCP) (Zhao et 
al., 2010). β-TRCP is an adaptor for SCF E3 ubiquitin ligases, which 
subsequently poly-ubiquitinates Yap, leading to its destruction by the 
proteasome (Zhao et al., 2010). Lats is thus able to regulate Yap activity 
spatially and temporally, through subcellular localization and protein 
stability respectively. Activation of the Hippo pathway therefore 
suppresses gene activation whilst inactivation of the pathway results in 
target gene expression.  
Upstream	regulators	of	the	Hippo	Pathway	
Whilst the regulation of Yap activity by the Hippo signalling kinase 
cascade is relatively well understood, the upstream regulators of Hippo 
signalling are only recently beginning to be defined.  
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G-Protein-Coupled	receptor	signalling	
G-Protein-coupled receptors are a large family of receptors that sense 
extracellular molecules and relay signals through associated G proteins. 
Upon binding of a ligand, the receptor acts as a guanine nuclear 
exchange factor (GEF), activating an associated G protein, which can 
then dissociate from the receptor and affect intracellular signalling 
(Reviewed in Wettschureck & Offermanns, 2005). Ligands such as 
lysophosphatidic acid and sphingosine-1-phosphate, that signal through 
receptors coupled to Gα12/13 or Gαq/11, have been found to inhibit Lats 
kinase, resulting in translocation of Yap to the nucleus and activation of 
target gene expression (Yu et al., 2012; Miller et al., 2012). However, 
ligands that signal through Gαs coupled receptors, such as adrenaline 
and glucagon can increase phosphorylation of Yap by Lats, thus 
decreasing nuclear Yap activity (Yu et al., 2012). 
Mechanical	cues,	cell	shape	and	the	actin	cytoskeleton	
Yap subcellular localization has been linked to mechanical cues. 
Culturing cells on a rigid surface that allows cells to spread results in 
nuclear localization of Yap and subsequent proliferation (Dupont et al., 
2011). Conversely, culture of cells on a compliant surface that does not 
favour cell spreading results in cytoplasmic localization of Yap and 
subsequent growth arrest (Dupont et al., 2011). These changes in the 
subcellular localization of Yap appear to be regulated by cell shape. 
Disruption of F-actin stress fibres results in increased phosphorylation 
and subsequent cytoplasmic localization of Yap (Wada et al., 2011; 
Sansores-Garcia et al., 2011). The spectrin cytoskeleton has also been 
found to influence the subcellular localisation of Yap (Fletcher et al., 
2015; Deng et al., 2015). Inhibition of myosin or Rho-kinase (ROCK), a 
Rho-GTPase effector important in generation of actin-myosin induced 
cellular tension also leads to increased cytoplasmic localization of Yap 
(Wada et al., 2011; Dupont et al., 2011). Mechanical cues therefore 
appear to be important in regulation of the subcellular localization of Yap, 
however the exact mechanisms by which actin affects the Hippo kinase 
cascade is unknown. 
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Cell	adhesion	&	polarity	
A fundamental hallmark of non-transformed cells in culture is cell-contact 
inhibition, such that upon reaching confluence, cells will cease to 
proliferate (Eagle, Levine & Koprowski, 1968). Cell contact mediated 
adhesion at high cellular density has been shown to result in activation of 
Hippo signalling, resulting in phosphorylation and subsequent 
cytoplasmic retention of Yap (Zhao et al., 2007). Furthermore 
overexpression of Yap confers cells with the ability to overcome cell-
contact inhibition (Zhao et al., 2007). This suggests that cell-cell contacts 
are important for regulation of Hippo signalling. 
Cell-cell contacts are also important for the establishment of epithelial 
apical-basal polarity. Apical-basal polarity is maintained by the action of 
protein complexes, which localize to specific positions along the apical-
basal axis. These protein complexes include the Crumbs complex, the 
Par/atypical Protein kinase C (aPKC) module, the Scribble module and 
the adherens junctions (Reviewed in Dow & Humbert, 2007). The Hippo 
pathway has been linked to many of these protein complexes. 
The Crumbs polarity complex associates with tight-junction complexes 
localised to the apical domain of polarized epithelial cells (Roh, 2003). 
Depletion of Crumbs components CRB3 or PALS results in decreased 
phosphorylation of Yap and increased nuclear Yap expression (Varelas et 
al., 2010). Angiomotin (Amot), another protein which associates with the 
Crumbs complex, has also been shown to interact with Yap resulting in 
increased phosphorylation and cytoplasmic retention (Zhao et al., 2011). 
In a similar manner to the Crumbs complex, Scribble promotes 
phosphorylation and cytoplasmic retention of Yap (Chen et al., 2012).  
Disruption of the adherens junction components α-catenin and E-
cadherin results in inactivation of the Hippo signalling pathway leading to 
Yap mediated cell proliferation (Schlegelmilch et al., 2011; Kim et al., 
2011). The tumour suppressor neurofibromin 2 (Nf2) has been shown to 
be upstream of the Hippo kinases, localized in close proximity to 
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adherens junctions where it may promote the appropriate protein 
scaffolds for activation of Lats (Moroishi et al., 2015). 
It is clear that multiple upstream inputs feed into the Hippo signalling 
pathway, including extracellular molecules, mechanical cues and 
information from cell polarity and adhesion.    
Yap	in	development	and	cell	fate	choice	
Despite its role as an oncogene (Overholtzer et al., 2006; Zender et al., 
2006; Steinhardt et al., 2008), Yap has also been found to be important in 
a number of cell fate decisions. Mesenchymal stem cells (MSCs) can 
differentiate into adipocytes or osteoblasts, depending on the stiffness of 
the culture conditions. On stiff surfaces MSCs will differentiate towards 
osteoblasts, whilst on soft surfaces MSCs will differentiate towards 
adipocytes (Engler et al., 2006). This was found to be linked to Hippo 
signalling, in that on stiff surfaces, Hippo signalling was inactivated, such 
that Yap could translocate to the nucleus (Dupont et al., 2011). More 
importantly, ectopic expression of Yap in MSCs cultured on soft surfaces 
resulted in differentiation towards osteoblasts (Dupont et al., 2011). This 
suggests that the mechanical regulation of Hippo signalling influences cell 
fate through regulation of Yap activity. 
Yap is important in mouse development, and Yap-/- mice die shortly after 
implantation at embryonic day (E) 8.5, exhibiting defects in yolk sac 
vasculogenesis and a shortened body axis (Morin-Kensicki et al., 2006).  
1.2 Pre-implantation	mouse	development	
The first two cell fate choices in the mouse embryo result in the 
specification of embryonic and extra-embryonic tissues (Figure 1.3). 
Specification of the first extra-embryonic lineage, the trophectoderm (TE) 
is important for formation of the placenta. The second extra-embryonic 
lineage gives rise to the primitive endoderm (PrE) which will form the 
parietal and visceral endoderm, as well as contributing to the embryonic 
gut (Kwon, Viotti & Hadjantonakis, 2008). Specification of the epiblast 
(Epi) from the inner cell mass (ICM) will give rise to the embryo proper 
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(reviewed in Schrode et al., 2013). Early blastomeres from the 2-cell to 8-
cell stages are totipotent, in that they can contribute to all lineages of the 
developing embryo, and following subsequent spatial segregation and 
cell lineage specification, blastomeres gradually lose their totipotency 
(Figure 1.3).  
 
Figure 1.3. Overview of mouse pre-implantation development. Schematic of 
pre-implantation development leading to formation of the blastocyst. E= 
embryonic day. (Figure from Schrode et al., 2013). 
Specification	of	the	TE	and	ICM	
The first cell fate decision, resulting in the specification of TE and the ICM, 
occurs following compaction of the embryo at the 8-cell stage, around 
embryonic day 3 of development (E3.0). Prior to compaction blastomeres 
are loosely connected and morphologically identifiable. Upon compaction, 
cell-cell contact adhesion increases through the adhesion molecule E-
cadherin and subsequently each blastomere becomes polarized along 
the apical-basal axis. Subsequent cell divisions give rise to blastomeres 
that occupy an inner or outer position within the embryo, with outer cells 
remaining polarized and inner cells becoming apolar. By the 32-cell stage 
(E3.5), the outer cells will form the TE and the inner cells will form the 
ICM (Figure 1.3). 
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The outer and inner cells also differ in their expression levels of lineage 
specific transcription factors (Guo et al., 2010). Cell fates are controlled 
by differential activity of lineage specific transcription factors. Specifically, 
caudal type homeobox-2 (Cdx2) is required for TE, while Nanog and Oct4 
specify the ICM lineage (Niwa et al., 2005; Ralston & Rossant, 2008; 
Strumpf et al., 2005; Nichols et al., 1998; Schöler et al., 1989). Initially at 
the 8-cell stage Cdx2 is expressed heterogeneously in all blastomeres 
but by the 32-cell stage, becomes restricted to the outer cells that will 
form the TE (Dietrich & Hiiragi, 2007). This restricted expression of Cdx2 
is required to repress the ICM lineage specific marker Oct4 (Niwa et al., 
2005; Ralston & Rossant, 2008; Strumpf et al., 2005). Cdx2 expression 
has been shown to be regulated by the transcription factor Tead4 
(Nishioka et al., 2008; Yagi et al., 2007). Tead4-/- embryos display 
significantly reduced Cdx2 and Gata3 expression and all their cells 
express markers of ICM (Ralston et al., 2010; Nishioka et al., 2008; Yagi 
et al., 2007). Tead4 has also been shown to directly regulate an enhancer 
of Cdx2 (Rayon et al., 2014). However Tead4 is expressed in the nucleus 
in all blastomeres (Nishioka et al., 2008), which presents the question of 
how the restricted expression of Cdx2 in outer cells occurs.  
The current model suggests that the key mechanism underlying this 
phenomenon is differential regulation of Yap by the Hippo signalling 
pathway (Figure 1.4). Inner cells have increased Hippo signalling, 
resulting in phosphorylation and cytoplasmic retention of Yap (Nishioka et 
al., 2009). In outer, polarized cells, Hippo signalling is inactivated, leading 
to the nuclear localisation of Yap. In the nucleus Yap binds Tead4 and 
promotes Cdx2 expression, thereby promoting TE cell fate (Nishioka et 
al., 2009).  
The differential activation of Hippo signalling in inner and outer cells is 
believed to be regulated by a combination of cell-cell adhesion and the 
polarity of the cell (Hirate et al., 2013). Disruption of the aPKC polarity 
complex activates Hippo signalling resulting in cytoplasmic Yap in all 
blastomeres at the 32-cell stage (Hirate et al., 2013). However, in 
dissociated embryos, this activation of the Hippo pathway was not seen, 
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suggesting a requirement in cell-cell adhesion for activation of the Hippo 
pathway (Hirate et al., 2013). The spatial regulation of Yap by the Hippo 
pathway is therefore important for the specification of TE and ICM cell 
fates. 
 
Figure 1.4. Specification of trophectoderm lineage via differential activity 
of the Hippo pathway. (A) Schematic of compact morula with inner cells 
highlighted in purple and outer cells highlighted in green. (B) Polarization of 
outer cells results in inactivation of Hippo signalling. Yap can translocate to the 
nucleus subsequently binding to Tead4 and drive expression of TE specific 
factors Cdx2 and Gata3. Conversely in unpolarized inner cells, Hippo signalling 
is activated, leading to phosphorylation and cytoplasmic retention of Yap, 
thereby preventing co-activation of Tead4. 
Specification	of	the	PrE	and	Epi	
The second cell fate decision occurs in the ICM, resulting in specification 
of the PrE and Epi lineages (Figure 1.5). The PrE becomes 
morphologically apparent by E4.5 as a layer of epithelial cells on the 
surface of the ICM, adjacent to the blastocyst cavity. This observation 
lead to early suggestions that ICM cells adjacent to the cavity 
differentiated towards PrE, in a positional manner similar to the induction 
of TE (Rossant, 1975). However, it has since been demonstrated that the 
ICM contains a heterogeneous population of PrE and Epi precursors 
which subsequently sorts into two defined populations (Chazaud et al., 
2006; Plusa et al., 2008).  
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Epi cells are marked by the pluripotency-associated factors Nanog, Sox2 
and Oct4 whilst PrE cells are marked by Gata6. Nanog and Sox2 are 
required for maintenance of the Epi (Mitsui et al., 2003; Avilion et al., 
2003).  Initially all cells of the ICM, up until the 32-cell stage, coexpress 
Gata6 and Nanog (Chazaud et al., 2006; Plusa et al., 2008). Following 
the 32-cell stage, cells of the ICM begin to upregulate lineage specific 
transcription factors, in a mutually exclusive manner, such that cells 
express either Nanog or Gata6 (Chazaud et al., 2006; Plusa et al., 2008). 
Fgf signalling has been implicated in the formation of this salt and pepper 
expression pattern such that, Fgf4 becomes down regulated in some ICM 
cells, whereas its receptor Fgfr2, is upregulated (Guo et al., 2010). 
Activation of Fgf signalling in these cells results in the upregulation of 
Gata6 and the repression of Nanog, biasing cells towards PrE 
(Frankenberg et al., 2011).  
After the 64 cell-stage, the heterogeneous population of PrE and Epi 
precursors sort into two distinct populations, with the PrE forming an 
epithelial layer on the surface of the ICM, adjacent to the blastocyst cavity. 
Live imaging of embryos which express a fluorescent reporter for the PrE 
marker Pdgfrα revealed that PrE cells reach the cavity by active migration 
(Plusa et al., 2008). However, cells adjacent to the cavity that were 
negative for Pdgfrα expression were occasionally seen to upregulate 
Pdgfrα and subsequently contribute to the PrE, whereas cells that 
express PrE markers, but do not reach the cavity were observed to 
undergo apoptosis (Plusa et al., 2008). This suggests that, whilst initial 
specification of PrE precursors may be independent of positional cues, 
the eventual sorting and formation of the PrE is position dependent.  
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Figure 1.5. Specification of the PrE and Epi lineages. Schematic of the 
expression of Gata6 (blue) and Nanog (Red) during the specification of the PrE 
and Epi lineages. E = embryonic day. (Figure from Xenopoulos et al., 2015). 
Whether the Hippo signalling pathway is important in the specification 
and sorting of PrE and Epi has yet to be elucidated. Depletion of Lats by 
siRNA treatment of embryos has been shown to result in failure of PrE 
formation (Lorthongpanich et al., 2013). Similarly deletion of the upstream 
Hippo pathway member Nf2 in embryos resulted in loss of PrE (Cockburn 
et al., 2013). The exact mechanisms underlying the loss of PrE in these 
embryos remains unknown.  
1.3 Mouse	embryonic	stem	cells	
Mouse embryonic stem cells (mESCs) are karyoptypically normal cell 
lines derived from the ICM of the mouse embryo during pre-implantation 
development (Evans & Kaufman, 1981; Martin, 1981). Embryonic stem 
cells are considered pluripotent, in that they retain the capability to 
differentiate into all lineages of the developing mouse embryo 
(Beddington & Robertson, 1989; Morgani et al., 2013). mESCs can be 
cultured in vitro, in medium containing leukaemia inhibitory factor (LIF), 
and foetal calf serum (Smith et al., 1988; Williams et al., 1988). In these 
culture conditions cells exhibit heterogeneous expression of markers of 
pluripotency such as Nanog and markers of PrE such as Gata6 or Hex 
(Chambers et al., 2007; Niakan et al., 2010; Morgani et al., 2013; 
Canham et al., 2010). LIF binds to a heterodimeric receptor, composed of 
the LIF receptor (LIFR) and glycoprotein 130 (gp130), resulting in 
activation of Janus associated tyrosine kinases (JAK) that phosphorylates 
signal transducer and activator of transcription 3 (STAT3). Subsequent 
dimerization of STAT3 and translocation to the nucleus allows expression 
of target genes (reviewed in Hirai, Karian & Kikyo, 2011). Although LIF 
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activates multiple signalling pathways, including mitogen activated protein 
kinase (MAPK) and Src family kinase (SFK) pathways, activation of 
STAT3 is sufficient for mESC self renewal in culture (Burdon et al., 1999; 
Anneren, 2004; Niwa et al., 1998; Matsuda et al., 1999). 
LIF has been shown to activate the SFK Yes, resulting in a subsequent 
tyrosine phosphorylation of Yap in mESCs (Tamm, Bower & Anneren, 
2011). This leads to Tead2 dependent transcription of the Oct4 promoter 
(Tamm, Bower & Anneren, 2011). Ectopic expression of a constitutively 
active form of Yap was found to induce expression of Oct4 and promote 
self-renewal in the absence of LIF (Lian et al., 2010). These findings are 
in contrast to the studies in pre-implantation mouse embryos, where Yap 
was restricted to the cytoplasm in cells of the pluripotent ICM (Nishioka et 
al., 2009).  
1.4 Conclusions	and	experimental	aims	
Yap is known to be one of the nuclear executors of the Hippo pathway. 
Regulation of Yap by the Hippo pathway is an important feature in cell 
fate specification in the mouse embryo. However, in mESCs Yap appears 
to be involved in self-renewal. Mouse embryonic stem cells provide an 
attractive model for the study of the function of Yap during self-renewal 
and differentiation. The aims of this work were therefore to address the 
role of Yap in these contexts. With the studies in the presented in the 
following chapters, I intended to: 
• Describe the subcellular distribution of Yap in the differentiation of 
mESCs 
• Establish whether Yap is involved in differentiation towards 
primitive endoderm cell fate in vitro 
• Establish whether Yap is involved in differentiation towards 
primitive endoderm cell fate in vivo 












Knockout Serum Replacement + LIF (KOSR+LIF): 
Knockout Dulbecco’s Modified Eagles Medium (Gibco, 10829-018) 
Knockout Serum Replacement 15% (Gibco 10828-028) 
Non-essential amino acids, 0.1mM (SIGMA; M7145) 
GlutaMAX, 2mM (Gibco, 35050-038) 
Sodium Pyruvate, 1mM (Gibco, 11360-039) 
2-mercaptoethanol, 0.1mM (Invitrogen, 21985-023) 
LIF, 100U/ml (Department of Biochemistry, University of 
Cambridge) 
Serum + LIF (SL): 
Glasgow Minimum Essential Medium (Gibco, 11580576) 
Foetal Bovine Serum, 10% (Labtech, batch number: 50115) 
Non Essential Amino Acids, 0.1mM (SIGMA; M7145) 
GlutaMAX, 2mM (Gibco, 35050-038) 
Sodium Pyruvate, 1mM (Gibco, 11360-039) 
2-mercaptoethanol, 0.1mM (Invitrogen, 21985-023) 
LIF, 100U/ml (Department of Biochemistry, University of 
Cambridge) 
Cytokines,	Growth	Factors	and	Inhibitors	





Phosphate Buffered Saline (PBS) (SIGMA D8537) 
Gelatin: 0.1% in PBS (SIGMA G1890) 
Trypsin: 0.05% Trypsin-EDTA (Thermo 25300-054) 
Doxycycline hydrochloride (SIGMA D-9891) 
Neomycin (Geneticin G418) (Gibco 11811-023) 
Puromycin (SIGMA) 
4OHT (tamoxifen) (SIGMA) 
Cell	Lines	
E14Tg2a: mESC line derived from 129/Ola mice (A generous gift from 
Prof. A. Martinez-Arias, University of Cambridge) (Hooper et al., 1987). 
IOUD2: mESC line containing LacZ reporter directly after the Oct4 
promoter (Mountford et al., 1994) 
Gata6-mCherry: Generous gift from Christian Schröter, mESC line with 
Gata6-mCherry inducible transgene, based on KH2 mESC line (Schröter 
et al., 2015) 
YapE08: Acquired from Knockout Mouse Project (KOMP) JM8 mESC 
clone derived from C57BL/6N mice. Contains Yap targeted Knockout-
First mutation  
2.2 Cell	Culture	
Routine	cell	culture:	
Mouse embryonic stem cells were cultured in media containing LIF (either 
KOSR+LIF or SL, (see Media and Supplements) on gelatin-coated tissue 
culture plastic at a cell density of 2.4x104cells/cm2, at 37°C, 5% CO2. The 
media was changed every day, and cells were passaged every 2-3 days. 
To passage, cells were washed twice with room temperature PBS, 
incubated with 0.05% trypsin for 5 minutes at 37°C, and re-suspended in 
media to neutralise the trypsin. For KOSR culture, any excess trypsin was 
removed before incubation at 37°C due to the lack of serum in the KOSR 
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media. Cells were centrifuged at 1000rpm for 3 minutes, re-suspended in 
fresh media and re-plated at the desired cell density.  
Freezing	Cells:	
To freeze mESCs, cells were washed twice with PBS, incubated with 
0.05% trypsin for 5 minutes at 37°C, re-suspended in media to neutralise 
trypsin, centrifuged at 1000rpm for 3 minutes, re-suspended in media 
containing 10% dimethyl-sulfoxide (DMSO), aliquoted into cryovials 
(Nunc 368-632) and immediately transferred to -80°C. The following day, 
the cryovials were transferred to liquid nitrogen for long-term storage. To 
thaw frozen cells, cryovials were removed from liquid nitrogen and 
warmed in a water bath at 37°C. Cells were re-suspended in 10ml of 
media and centrifuged at 1000rpm, before resuspension and plating on 
gelatin-coated tissue culture plastic. 
2.3 Cell	culture	assays	
LIF	Removal:	
mESCs were cultured in KOSR+LIF for at least two passages prior to 
experiments. Cells were trypsinised and re-plated onto gelatin-coated 
25mm tissue culture plastic round coverslips (Nunc, 174-985) in 6-well 
tissue culture plates (GreinerBioOne, 657160) at a density of 
2.4x104cells/cm2, in media with or without LIF. Media was changed daily, 
and replaced with media with or without LIF. Following 48 hours cells 
were washed twice with BBS-CaCl2 (see Reagents for immunostaining) 
before fixation with 4% PFA for subsequent immunostaining. 
Spontaneous	Differentiation	towards	PrE:	
mESCs were cultured in KOSR+LIF for at least two passages prior to 
experiments. Cells were trypsinised and re-plated onto gelatin coated 
25mm tissue culture plastic round coverslips in 6-well tissue culture 
plates at a density of 2.4x104cells/cm2 in KOSR+LIF. Media was changed 
daily. Following 48 hours, cells were washed twice with BBS-CaCl2 (see 
Reagents for immunostaining) before fixation with 4% PFA for 
subsequent immunostaining.  
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Embryoid	Bodies:	Hanging	Drop	method	
mESCs were trypsinised and re-suspended in KOSR+LIF at a density of 
1x105 cells/ml. 10µl drops of media, containing approximately 1000 cells 
were placed onto the underside of a sterile petri dish lid, before being 
inverted and cultured at 37°C, 5% CO2. The petri dish contained PBS to 
prevent the drops from drying out. After 48 hours embryoid bodies, were 
collected by washing with PBS and either fixed in 4% PFA or transferred 
into petri dishes containing KOSR+LIF for continued suspension culture. 
Embryoid	Bodies:	Cell	aggregate	method	
The method of generating embryoid bodies by cell aggregation was 
adapted from (Li & Yurchenco, 2006). mESCs were cultured on mouse 
embryonic fibroblasts in KOSR +LIF. When confluent, cells were washed 
twice with PBS and then trypsinised. Crucially, trypsinisation was 
monitored under a microscope and neutralised by addition of media only 
when the mESC colonies lifted up off the fibroblasts. The mESC colonies 
were collected into a 15ml tube and allowed to pellet by gravity. The 
supernatant was then aspirated and the pellet re-suspended using a 
glass Pasteur pipette. The mESC aggregates were then allowed to pellet 
by gravity a second time before re-suspending in 2ml of KOSR+LIF 
media (see Media and Supplements) and trituration with a Pasteur pipette 
in order to create clusters of cells containing 3-7 cells each. The mESC 
clusters were then transferred to a sterile petri dish at a density of 
approximately 103 cell clusters per dish and incubated at 37°C, 5% CO2. 
The media was changed after 3 days of culture and then every day up to 
a maximum of 7 days. Embryoid bodies that displayed endodermal 
differentiation (assessed by the presence of an outer later of flattened 
cells visible under phase-contrast microscopy) and cavitation were 
selected and fixed in 4% PFA for subsequent immunofluorescence 
analysis. 
Inducible	Gata6-inducible	model	of	differentiation:	
Gata6-inducible mESCs were cultured in S+L for at least two passages 
prior to experiments. Cells were trypsinised and re-plated onto gelatin 
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coated 25mm tissue culture plastic round coverslips in 6-well tissue 
culture plates at a density of 5x104 cells per well, in S+L containing 1µM 
PD03. Thereafter the media was changed daily. After 3 days, PD03 was 
excluded from the media and Gata6 was induced by addition of 500ng/ml 
doxycycline. After 6 hours of induction, cells were either washed twice in 
BBS-CaCl2 and fixed in 4% PFA or placed in S+L for a further 24 hours 
before washing and fixation in 4% PFA. No-doxycycline treated control 
cells were fixed alongside the 6h doxycycline-treated cells. The Hippo 
signalling inhibitors were added to the media with doxycycline following 3 
days of PD03 treatment, and either removed after 6 hours, or kept in the 
media for the following 24 hours. 
Cell	culture	on	hydrogels	of	varying	compliance	
Hydrogels were prepared as described in (Cretu, Castagnino & Assoian, 
2010): 
Table 2.1. Reagents for preparation of polyacrylamide hydrogels 
Name Source 










Glass coverslips were sterilized by autoclave, and covered in 1M NaOH 
for 3 minutes. NaOH was aspirated and coverslips were covered in 3-
APTMS and incubated for 3 minutes. 3-APTMS (Table 2.1) was aspirated 
and coverslips washed 3x10 minutes in deionized water. Excess water 
was aspirated and coverslips were coated in 0.5% glutaraldehyde in 
sterile deionized water and incubated for 30 minutes. Glutaraldehyde was 
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aspirated and coverslips washed 3x10 minutes in deionized water, before 
being dried completely in air.  
Hydrogel preparation:  
Acrylamide (AC), bis-acrylamide (Bis-AC), water, APS, TEMED and NHS 
(Table 2.1) were added to a micro-centrifuge tube in varying ratios 
depending on the desired compliance, as in Table 2.2.   
Table 2.2. Volumes of reagents for acrylamide hydrogels 
 0.7kPA 4kPA 40kPA 
Water 618 522 402 
AC 150 150 150 
Bis-AC 24 120 240 
APS 8 8 8 
TEMED 1 1 1 
NHS 228 228 228 
 
The contents of the micro-centrifuge tube were vortexed and immediately 
poured onto pre-treated coverslips. A siliconized coverslip was used to 
‘sandwich’ the acrylamide solution onto the coverslip, allowing the 
solution to solidify. Once the hydrogel had solidified, the siliconized 
coverslip was removed and discarded, and the now hydrogel coated 
coverslip was placed into a 6 well tissue culture dish and washed 3x5 
minutes in PBS. Hydrogels were coated with a 0.2mg/ml solution of Type 
1 collagen in PBS overnight at 4°C. The collagen solution was then 
aspirated, and hydrogels washed twice with PBS. mESCs could then be 
plated onto the hydrogels, as in routine cell culture.  
2.4 Electroporation,	Selection	and	picking	of	colonies	
Transient	expression	of	pCAGGS-FLP-PURO	
One day prior to electroporation 40µg pCAGGS-Flp-Puro plasmid was 
precipitated with ethanol, washed twice with 70% ethanol and re-
suspended in 0.1ml PBS in a micro-centrifuge tube. The media was 
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changed on cells 3-4 hours prior to electroporation. Cells were trypsinised 
as routine and re-suspended in PBS. Cells were centrifuged at 1000rpm 
for 3 minutes, re-suspended in 0.7ml room temperature PBS and added 
to the micro-centrifuge tube containing the pCAGGS-Flp-Puro plasmid. 
Cell and plasmid suspension was transferred to an electroporation 
cuvette (0.4cm gap; BioRad) and electroporated using a BioRad Gene 
Pulser II with high capacitance extender unit, set to 250V / 500µF giving 
approximately 6-7ms time constant. Cells were allowed to recover for 20 
minutes before being plated in KOSR+LIF onto gelatin-coated 10cm 
tissue culture dishes (Nunc) at 5x106, 2x106 or 1x106 cells per dish. The 
medium was changed daily. 36 hours post electroporation; the media was 
replaced with medium containing 1µg/ml puromycin, and selection was 
maintained for 48 hours. Following removal of the selection antibiotic, 
surviving colonies were cultured until they reached approximately 1mm in 
diameter.  
Targeting	the	Yap	locus	using	KOMP	knockout	first	targeting	vector	
Cells were electroporated as described in Transient expression of 
pCAGGS-FLP-PURO with the following modifications: 
• 15µg of Yap targeting Vector plasmid was linearised by restriction 
digest with AsiSI  
• 2-3x107 cells were electroporated  
• BioRad Gene Pulser II with high capacitance extender unit, set to 
800V / 3µF giving approximately 0.04ms time constant 
• Cells plated at 5x106, 2x106 and 1x107 cells per dish.  
• 24 hours after electroporation, drug selection began with the 
addition of 150µg/ml G418 to the culture medium. Selection was 
maintained until colonies grew to approximately 1mm in diameter. 
Targeting	CreERT2	to	the	ROSA26	locus	
Cells were electroporated as described in Transient expression of 
pCAGGS-FLP-PURO with the following modifications: 
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• 5µg of pMB80 plasmid was linearised by restriction digest with 
AscI,  
• One confluent 25cm2 tissue culture flask was electroporated 
• BioRad Gene Pulser II with high capacitance extender unit, set to 
230V / 500µF giving approximately 6-7.5ms time constant 
• Cells were re-suspended in 3ml of media. 1 and 2ml of cell 
suspension were made up to 10ml in S+L and plated onto two 
gelatin coated 10cm tissue culture dishes 
• 24 hours after electroporation, drug selection began with the 
addition of 1µg/ml puromycin to the culture medium. Selection was 
maintained until colonies grew to approximately 1mm in diameter. 
Picking	clonal	colonies	
Media in the 10cm dish was replaced with PBS and colonies were picked 
in a volume of 15µl using a 20µl Pipetteman under a dissecting 
microscope. Each colony was dispensed into a well of a 96-well round 
bottom plate containing 15µl of trypsin and incubated for 15 minutes at 
37°C. 170µl of media+LIF was then added to the wells, and the cell 
suspensions transferred to a gelatinized 96-well tissue culture plate. 
Media was changed every day until most of the clones became confluent.  
2.5 Mouse	Husbandry	
All mouse work was approved by the University of Bath Animal Welfare 
and Ethical Review Body (AWERB) and undertaken under UK Home 
Office license PPL 30/3219 in accordance with the Animals (Scientific 
Procedures) Act incorporating EU Directive 2010/63/EU. CD1 Mice were 
maintained by in-house breeding on a lighting regime of 14 hours light 
and 10 hours darkness with food and water supplied ad libitum. Embryos 
were generated by natural mating. Detection of a copulation plug 
confirmed successful mating. The resulting embryos were then 
considered to be embryonic day 0.5 (E0.5). Blastocysts were collected at 
E3.5 and E4.5. 
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2.6 Blastocyst	collection		
Pregnant female mice were sacrificed by cervical dislocation. The 
abdominal cavity was cut open using fine scissors and fat and digestive 
organs were moved to the side to facilitate visualisation of the uterus. The 
uterus was held with fine forceps, cut across the cervix and lifted in order 
to remove mesometrium membrane before removal by cutting of the 
utero-tubal junction as shown in Figure 2.1. The uterine horns were 
placed in a 35mm petri dish containing PBS. Using a Leica MZ12 
stereomicroscope, the remaining fat and mesometrium were carefully 
removed from the uterine horns. Using fine scissors, the end side of each 
uterine horn was cut, and embryos were flushed from the uterus by 
injection of M2 medium (Millipore; MR-015-D) into the cervix. Embryos 
were collected from the medium by mouth pipette and placed into a fresh 
drop of M2 media, before subsequent processing.  
 
Figure 2.1. Dissection of the mouse uterus. (A) Illustration of mouse uterus, 
indicating where cuts were made across the cervix and utero-tubal junction. (B) 
Illustration of the mouse uterus being flushed by injection of M2 media into the 




BBS:  25mM BES Salt (SIGMA B2891) 
 140mM NaCL 
 0.75mM Na2HPO4 
 
BBT-BSA: BBS 
  1mM CaCl2  
  0.1% Triton-X100 
  0.5% Bovine Serum Albumin (Roche) 
 
BBS-CaCl2:  BBS 
  1mM CaCl2 
 
Paraformaldehyde (PFA): 4% PFA diluted in BBS + 1mM CaCl2 
 
Immunostaining	of	mESCs	
Following fixation in 4% PFA in BBS+CaCl2, samples were permeabilised 
by rinsing 3 times before 3 washes of 15 minutes in BBT-BSA (see 
Reagents for immunostaining). Samples were then incubated with 
primary antibody (Table 2.3) diluted in BBT-BSA and incubated in a 
humid chamber at 4°C overnight. The following day, primary antibody 
was removed by rinsing 3 times before 3 washes of 15 minutes in BBT-
BSA. Samples were then incubated with the appropriate secondary 
antibody (Table 2.4) diluted in BBT-BSA for 2 hours at room temperature, 
away from light. Secondary antibody incubations were performed 
sequentially if any were raised in the same species as the primary 
antibodies. A nuclear stain (Table 2.5) was included in the secondary 
antibody incubation. Secondary antibody was removed by rinsing 3 times 
before 3 washes of 10 minutes in BBS+CaCl2. Samples on coverslips 
were placed cell side up on a glass slide, before mounting a glass 
coverslip on top with HMM (4% N‐propyl‐galate, 80% glycerol).  
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Immunostaining	of	mouse	pre-implantation	embryos	
The zona pellucida of E3.5 embryos was removed using Tyrode’s acidic 
solution (SIGMA T1788). Embryos were transferred to a siliconised glass 
dish and fixed in 4% PFA in BBS+CaCl2 for 15 minutes at room 
temperature. Following a rinse in PBS/PVP (PBS containing 
polyvinylpyrrolidone-40 (SIGMA)), embryos were permeabilised in a 
solution containing 0.25% Triton-X100 in PBS/PVP for 30 minutes at 
room temperature. Embryos were subsequently blocked for 15 minutes in 
a blocking buffer containing 0.1% BSA, 0.01% Tween20 and 2% donkey 
serum (SIGMA D9663) in PBS. Embryos were then incubated with 
primary antibody (Table 2.3) diluted in blocking buffer at 4°C overnight in 
a humid chamber. The following day, primary antibody was removed by 
washing the embryos 3 times for 15 minutes in blocking buffer. Embryos 
were subsequently incubated with secondary antibody (Table 2.4) diluted 
in blocking buffer for 1-3 hours at room temperature away from light. 
Secondary antibody incubations were performed sequentially if any were 
raised in the same species as the primary antibodies. Either Hoechst or 
Topro3 (Table 2.5) was included as a nuclear stain, in the secondary 
antibody incubation. Secondary antibody was removed by washing the 
embryos 3 times for 15 minutes in blocking buffer. To mount, embryos 
were taken through an increasing concentration series of Vectashield 
(Vector Laboratories) and mounted in 100% Vectashield on glass slides.  
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Table 2.3. List of Primary antibodies used for immunofluorescence  
Antibody Host Manufacturer Catalogue 
number 
Dilution 
Yap Rabbit Cell Signalling 4912 1:200 
Yap Rabbit Santa Cruz 15407 1:200 
pYap(S127) Rabbit Cell Signalling 4911 1:200 
Oct4 Mouse Santa Cruz 5279 1:200 
Nanog Rat eBIOSCIENCE 14-5761-80 1:200  
Gata4 Rabbit Santa Cruz SC9053 1:200 
Gata6 Goat R&D Systems AF1700 1:200 
 
Table 2.4. List of secondary antibodies used for immunofluorescence  
Antibody Host Manufacturer 
Alexa Fluor 488 – conjugated anti Mouse Goat Invitrogen 
Alexa Fluor 488 – conjugated anti Rabbit Goat Invitrogen 
Alexa Fluor 488 – conjugated anti Goat Donkey Invitrogen 
Alexa Fluor 546 – conjugated anti Rabbit Goat Invitrogen 
Alexa Fluor 568 – conjugated anti Mouse Goat Invitrogen 
Alexa Fluor 568 – conjugated anti Goat Donkey Invitrogen 
Alexa Fluor 633 – conjugated anti Mouse Goat Invitrogen 
Alexa Fluor 633 – conjugated anti Rabbit Goat Invitrogen 
Alexa Fluor 633 – conjugated anti Rat Goat Invitrogen 
Alexa Fluor 568 – conjugated anti Rat Goat Invitrogen 
 
Table 2.5. List of nuclear stains used for immunofluorescence  
Nuclear stain Manufacturer Dilution 
Hoechst 3342 Invitrogen 1: 1000 




To stain for β-galactosidase, 0.1M-phosphate buffer was prepared by 
dissolving 3.74g/L monobasic sodium phosphate and 10.35g/L dibasic 
sodium phosphate in distilled water, and adjusting the pH to 7.3 using a 
p.H. meter. Media was aspirated and cells were fixed in fix solution (5nM 
EGTA, 2mM MgCl2 and 0.2% glutaraldehyde in phosphate buffer) for 5 
minutes. The fixed solution was aspirated and cells washed twice for 5 
minutes in wash solution (2mM MgCl2 in phosphate buffer). Cells were 
then incubated in staining solution (2mM MgCl2, 5mM potassium 
ferrocyanide, 5mM potassium ferricyanide, 1mg/ml X-Gal in phosphate 
buffer and filtered before use) overnight at 37°C. Presence of β-
galactosidase was indicated by a blue colour.  
2.8 Molecular	Biology	
Genomic	DNA	isolation	from	mESCs	
Cells were lysed in lysis buffer (20mM Trizma-HCl pH8, 50mM EDTA, 
50mM KCl, 100mM NaCl, 0.5% (wt/vol) SDS, 0.1% (vol/vol) Igepal, 0.1% 
(vol/vol) Tween-20, 400µg/ml RNAseA, Proteinase K 1mg/ml) at 60°C 
overnight. DNA was precipitated using 100% isopropanol, washed twice 
in 70% ethanol and re-suspended in TE containing 20µg/ml RNAseA. 
Genomic	PCR	
PCR Master mix:  2X PCR ReddyMix (Thermo) 10µl  
(per reaction)  Forward Primer 10µM  1µl 
   Reverse Primer 10µM  1µl 
   H20     6 µl 
   DNA template   1µl 
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PCR Cycle: Step 1: 94°C 
  Step 2: 94°C 
  Step 3: 58°C 
  Step 4: 72°C 
  Step 5: Repeat steps 2-4 for 30 cycles 
  Step 6: 72°C 
  Step 7: hold at 4°C 
PCR was amplified using an MJ research PTC200 thermocycler. 
Resulting PCR products were run on a 1% agarose gel. Primers used in 
PCR analysis are listed in Table 2.6. 
Long-Range	PCR	
PCR MasterMix:  2 µL 5X LongAmp Taq Reaction Buffer 
0.16 µL DMSO 
0.3 µL 10 mM dNTPs 
0.4 µL 10 µM Forward Primer 
0.4 µL 10 µM Reverse Primer 
10-50 ng Template DNA 
0.4 µL LongAmp Taq DNA Polymerase 
Nuclease-free water to 10 µL 
 
 PCR Cycle: Step 1: 93°C  3 mins 
  Step 2: 93°C  15 secs 
  Step 3: 65°C  30 secs decreasing 1°C/cycle 
  Step 4: 65°C  9 mins 
  Step 5: Repeat steps 2-4 for 8 cycles 
  Step 6: 92°C  15 secs 
  Step 7: 55°C  30 secs 
  Step 8: 65°C  8 mins increasing 20 sec/cycle 
  Step 9: 65°C  9 mins 
  Step 10: hold at 4°C 
 
LongAmp Taq PCR Kit (New England Biolabs) was used for long range 
PCR amplification. PCR was amplified using an MJ research PTC200 
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thermocycler. Resulting PCR products were run on a 1% agarose gel. 
Primers used in PCR analysis are listed in Table 2.6. 
Analysis	of	mRNA	expression	(RT-PCR)	
Cells cultured in 6 well plates were washed twice with PBS. RNA was 
extracted using Tri reagent (SIGMA). Chloroform was used to separate 
the RNA, which was then precipitated using isopropanol. Following 
centrifugation, the resulting pellet was washed with 75% ethanol, dried, 
and suspended in RNAse-free water. RNA was quantified using a 
nanophotometer (Implen, Munich, Germany). Contaminating DNA was 
removed via treatment with DNase (Ambion). cDNA was generated with 
the SuperScript II Reverse transcriptase kit (Invitrogen). cDNA was 
amplified by PCR using intron spanning primers, and compared to β-actin 
as a control.   
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Table 2.6. List of primers used in PCR analysis 
Primer Name Sequence 5’-3’  
F Yap Exon3 ATCAGACAACAACATGGCAGGAC 
F5' Yap Crit GTCTTTGTTAGGGCTCTTTGG 
R3' Yap Crit CGTGATGGTAGGAGAACAGAC 
YAP rt F ACCCTCGTTTTGCCATGAAC 
YAP rt R TGTGCTGGGATTGATATTCCGTA 
En2R: 5' TGTTAGTCCCAACCCCTTCCTCC 
NF: 5' GGTACCGCGTCGAGAAGTTCCTATT 
LR: 5' TGAACTGATGGCGAGCTCAGACCAT 
5' YAP (GF4) CAGACTTCACTCTTGCCAAGCTTGGTGC 
5' YAP (GF3) CTCTCACTCCAGACTTCACTCTTGCCAAGC 
3' YAP (GR4) CAAGGTTCTATAAGTACAATAAGTCCAATC 
3' YAP (GR3) CAACTCAATACAACTACTCTGGTATGTAC 
β-actin F AAGAGCTATGAGCTGCCTGA 




To allow for quantitative comparison between cells under different 
conditions in an experiment, all cells were stained at the same time with 
the same staining conditions and imaged in one session. An average of 
5-10 mESC colonies from each condition were imaged. 512x512 pixels 
(201.64µm x 201.64µm) fluorescent images of mESCs were acquired 
using a Zeiss LSM 510 Meta confocal laser-scanning microscope, and a 
Plan-Apochromat 63x/1.4 Oil Ph3 objective with 0.7x zoom and 
246.03µm x 246.03µm images acquired using a Leica SP5-II confocal 
laser scanning microscope Zeiss LSM 510 Meta confocal laser-scanning 
microscope and a HCX PL APO CS 63.0x1.40 OIL UV objective. A 
representative section of each colony was analysed using MINS. 
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Imaging	pre-implantation	mouse	embryos	
To allow for quantitative comparison between embryos in an experiment, 
all embryos were immunostained together at the same time with the 
same staining conditions. 512x512 pixels (201.64µmx201.64µm) with 
optical section thickness of 1µm fluorescent images of mouse embryos 
were acquired using a Zeiss LSM 510 Meta confocal laser-scanning 
microscope, using a Plan-Apochromat 63x/1.4 Oil Ph3 with 0.7x zoom.  
Segmentation	using	MINS	
Fluorescent images of mESCs and embryos were segmented and 
quantified using modular interactive nuclear segmentation (MINS), a 
MATLAB based segmentation tool designed for counting cells and 
measuring fluorescent intensity of 2D and 3D image data (Lou et al., 
2014). MINS detects nuclei from the nuclear label e.g. Hoechst, 
segments individual nuclei and applies an overlay mask which allows 




Figure 2.2. Modular Interactive Nuclear Segmentation (MINS), (A) The main 
graphical user interface (GUI) of MINS (B), the result of segmentation of mESCs 
showing overlay of individual cells of a colony (C) and array of data produced 
with average fluorescent intensity values of cells for each channel highlighted. 
Classification	of	cell	lineage	in	pre-implantation	mouse	embryos	
In the analysis of embryos, MINS will also automatically assign a cell 
identity of either trophectoderm or inner cell mass based on the distance 
from the centre of the embryo (Figure 2.3). These classifications were 
checked manually by comparing Z-stack images embryos to the assigned 
overlay identities. Cells of the PrE in E4.5 embryos were classified 
manually by their location and expression of Gata6. Trophectoderm and 
inner cell mass cells were analysed independently. 
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Figure 2.3. MINS Segmentation of embryo nuclei and assignment of 
lineage. (A) MINS segmentation of nuclei in one Z-section of an embryo, (B) 
MINS allocation of lineage, cells of the ICM and TE are assigned. 
 
Adjusting	for	image	intensity	loss	along	the	Z-axis	
Image acquisition using confocal imaging leads to fluorescent intensity 
loss with depth due to absorption or scattering of excitation and 
fluorescence.  In order to correct for this, embryos were mildly 
compressed upon mounting to reduce the thickness of the sample. 
Furthermore, the fluorescence intensity of each channel in each cell was 
plotted against the Z-axis, such that the drop in intensity could be 
visualised (Figure 2.4). Cells above the Z-location in which fluorescence 
intensity starts to drop were discarded from any analysis.  
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Figure 2.4. Fluorescence intensity loss along the Z-axis in mouse embryos. 
(A) Representative confocal section with orthographic projections of the Z-axis. 
(B) Graph representing fluorescent intensity (arbitrary units) decay as Z (µM) 
increases. 
Staging	of	mouse	embryos	
In order to study molecular mechanisms of mouse pre-implantation 
development, correct staging of embryos is important. Developmental 
staging of embryos is based on time since fertilization and morphological 
features therefore developmental stages can encompass a range of 
molecular events. Factors such as genetic background of mice can affect 
developmental timing (Molls, Zamboglou & Streffer, 1983), Embryos were 
therefore staged according to their total cell number and expression 
pattern of Gata6 and Nanog (Table 2.7).  
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Table 2.7. Staging of mouse pre-implantation embryos  
 Gata6/Nanog Expression pattern Total cell number 
E3.5 Co-expression 32-60 
E4.0 ‘Salt and Pepper’ 60-120 
E4.5 Sorted >120 
 
Defining	thresholds	using	mixture	analysis	
In order to determine whether cells were positive for expression of 
markers over background levels, threshold limits were defined using 
mixture analysis. Mixture analysis is a method for estimating the 
parameters of two or more univariate normal distributions based on 
pooled data. Fluorescent intensity values of Gata6 or Nanog were 
determined from MINS analysis and mixture analysis was performed 
using Paleontological Statistics (PAST) data analysis software. 
Thresholds were determined as where the two estimated distributions 
met (Figure 2.5), with mixture analysis automatically allocating each data 
point into one of the two groups. Mixture analysis was performed using 
data from E4.5 embryos, and end stage of PrE differentiation in mESCs, 
as at these points it was considered that Gata6 and Nanog levels in cells 
exist in bimodal states i.e. protein is either expressed or not at these time 
points. These thresholds were then applied to earlier stages in order to 
generate population data based on Gata6 and Nanog expression.  
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Figure 2.5. Mixture analysis using PAST. An example of mixture analysis, 
Gata6 intensity values are plotted as a histogram, with the predicted normal 
distributions displayed in red. The likelihood that the data can be represented as 
the specified number of groups (in this case 2) is displayed as the likelihood 
value, with lower negative log values indicating increased likelihood. Threshold 
value is determined as where the two populations meet.     
Fluorescent	intensity	profiling		
For quantifying cytoplasmic Immunofluorescence intensity, linear profiles 
were generated using ImageJ. Grayscale values for each linear profile 
were plotted as a histogram and averaged to obtain the mean intensity 
value. At least 3 intensity profiles were analysed per experimental group.  
2.10 Statistical	Analysis	
Statistical analysis was performed using GraphPad Prism 6 software. 
Significant difference between experimental groups was determined by 
one-way ANOVA followed by Tukey’s post hoc test for experiments with 
three or more groups and Student’s T-test for experiments with two 
groups. 
A statistically significant difference was accepted if P<0.05. Significance 
is indicated on graphical representations of the data by the marks: 






Chapter 3:  The role of Yap in differentiation of 




While the role of Yap as an oncogene and as an effector of the Hippo 
pathway is well established (Overholtzer et al., 2006; Zender et al., 2006; 
Steinhardt et al., 2008), its role in cellular differentiation is less well known. 
Yap is involved in cellular differentiation in several contexts. In the 
developing airways of the mouse embryonic lung, ablation of Yap results 
in the loss of epithelial differentiation (Mahoney et al., 2014). Yap is also 
required for optic vesicle progenitors to adopt a retinal pigment epithelia 
cell fate in zebrafish (Miesfeld et al., 2015), and in mouse pre-
implantation development, nuclear Yap increases expression of Cdx2, 
which leads to differentiation towards the trophectoderm (TE) fate 
(Nishioka et al., 2009). It may therefore be possible that nuclear Yap is a 
general feature for differentiation in any cellular context. 
Mouse embryonic stem cells (mESCs) are pluripotent cells derived from 
the pre-implantation mouse blastocyst, which retain the potential to 
differentiate into cells of all lineages (Evans & Kaufman, 1981; 
Beddington & Robertson, 1989). mESCs are therefore an excellent model 
system in which to study the expression of Yap during differentiation. As 
Yap mRNA is enriched in mESCs compared to differentiated cells 
(Ramalho-Santos et al., 2002), this indicates that this model is valid for 
the study of Yap during differentiation. 
3.2 Expression	of	Yap	during	differentiation	of	mESCs	
In order to investigate the role of Yap in the differentiation of mESCs, one 
approach is to remove the signal maintaining the pluripotent state and 
determine the expression of Yap. LIF is an essential cytokine for the 
maintenance of pluripotency and in its absence mESCs spontaneously 
differentiate (Smith et al., 1988; Williams et al., 1988). If levels of Yap 
change following LIF withdrawal, this would suggest that regulation of 
Yap changes upon differentiation.  
mESCs were induced to differentiate by LIF withdrawal, and nuclear Yap 
levels were measured. As Yap acts as a transcriptional co-activator, 
nuclear localization is required for activation of target gene expression 
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(Zhao et al., 2007). Yap activity can be regulated via phosphorylation by 
the Hippo signalling pathway leading to cytoplasmic retention and thus 
prevention of transcriptional co-activation. Therefore the amount of Yap in 
the nucleus provides an indication of Yap activity. Nuclear Yap intensity 
was measured by quantitative immunofluorescence following 
segmentation of cell nuclei with MINS (Modular Interactive Nuclear 
Segmentation) (Lou et al., 2014). This method allows measurement of 
fluorescent intensity of immunostaining in the nucleus at the single cell 
level, which infers the levels of proteins (Muñoz Descalzo et al., 2012). 
E14Tg2a mESCs were cultured for either 24 or 48 hours with or without 
LIF, fixed and then immunostained for Yap and the markers of 
pluripotency Nanog and Oct4 (Figure 3.1A) and analyzed by quantitative 
immunofluorescence analysis (Figure 3.1B,C). The results of this analysis 
for each protein are shown using distribution plots (Figure 3.1B) and box 
and whisker plots (Figure 3.1C). As expected the nuclear intensity of 
Nanog and Oct4 decreased following 48-hours of LIF withdrawal 
compared to cells grown in the presence of LIF indicating that the mESCs 
were indeed differentiating (Figure 3.1B,C). Following 24-hours of LIF 
withdrawal, nuclear Yap intensity was increased compared to control. 
However after 48-hours of LIF withdrawal, nuclear Yap intensity was 
found to be lower than control (Figure 3.1B,C). This transient increase in 
nuclear Yap upon LIF withdrawal suggests that Yap could be involved in 
the early phase of mESC differentiation. Interestingly, following 24-hours 
of LIF withdrawal, nuclear Oct4 intensity was also increased (Figure 
3.1B,C). Elevated levels of Oct4 have previously been shown to be 
associated with differentiation of mESCs (Niwa, Miyazaki & Smith, 2000) 
and Oct4 is required for specification of the Primitive Endoderm (PrE) in 




Figure 3.1. Nuclear Yap intensity increases following withdrawal of LIF. (A) 
Representative confocal images of E14Tg2A cells stained for Hoechst (blue), 
Yap (green), Nanog (red) and Oct4 (Magenta) grown in KOSR for 48 hours with 
LIF as indicated. Scale bar: 50 µm. (B) Distributions of Yap, Nanog and Oct4 in 
E14Tg2A cells cultured in KOSR+LIF (blue line), KOSR-LIF(24h) (orange line) 
and KOSR-LIF(48h) (green line). Fluorescence levels (grayscale) were 
quantified for each individual cell, binned in 20 logarithmically spaced classes (x 
axis); the frequency of each bin is shown on the y-axis here and in similar 
graphs. (C) Box and whisker plots displaying intensity levels of Yap, Nanog and 
Oct4 in indicated culture conditions. Solid line indicates median values, while 
cross indicates mean value here and in similar graphs. **=P<0.001, 
****=P<0.0001 by one-way ANOVA with Tukey’s post-hoc test. n=at least 280 
cells per culture condition. Data shown is representative of two independent 
experiments. 
A previous study has shown that mESCs can spontaneously differentiate 
into PrE-like cells in standard mESC culture conditions i.e. serum + LIF 
(Niakan et al., 2010). To examine if expression of Yap in this 
spontaneous differentiation towards PrE-like cells, E14Tg2a mESCs were 
cultured in standard mESC culture conditions and then immunostained 
for Yap, Nanog and Gata6 (Figure 3.2A). Gata6 is an early marker of PrE 
(Cai et al., 2008). Immunostaining revealed spontaneously differentiating 
cells that express Gata6, with low expression levels of Nanog (Figure 
3.2B). The cells expressing Gata6 appeared to have increased nuclear 
Yap when compared to the surrounding cells (Figure 3.2B). In this 
experiment 3.2% of cells spontaneously expressed Gata6. 
Immunostaining was then analyzed using quantitative 
immunofluorescence analysis. Nuclear Gata6 intensity of each cell was 
plotted against nuclear Nanog intensity to give a graphical representation 
of the population of cells (Figure 3.2C). Nuclear Yap intensity of each cell 
was then plotted as a heat-map, revealing that cells with higher nuclear 
Gata6 (bottom right of the graph) intensity also have higher nuclear Yap 
intensity compared to cells not expressing Gata6 (Figure 3.2B). This is 




Figure 3.2. Nuclear Yap intensity is increased in cells spontaneously 
differentiating towards PrE fate (A) Representative confocal images of 
E14Tg2A cells stained for Hoechst (blue), Yap (green), Gata6 (red) and Nanog 
(Magenta) grown in KOSR for 48 hours with LIF, Scale bar: 50 µm (B) Magnified 
sections of dashed areas in A. Arrows indicate cells expressing Gata6. (C) 
Scatter plot showing Gata6 (x-axis), Nanog (y-axis) and Yap (heat map, side 
bar) nuclear intensity in fluorescence arbitrary units (AU). Each dot represents 
the levels in a single cell. 564 cells were analysed. Dashed oval indicates cells 
expressing Gata6. Images shown are representative of two independent 
experiments. 
Later markers of PrE such as Gata4 have also been shown to be 
expressed in standard culture of mESCs (Niakan et al., 2010). 
Expression of Gata4 was examined in mESCs cultured in standard 
culture conditions. IOUD2 cells were cultured for 72 hours, fixed and 
expression of Gata4 or Yap was examined by immunostaining. 
Expression of Gata4 was most often observed in cells located at the 
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periphery of colonies (Figure 3.3B). This is analogous to expression of 
Gata4 in the PrE of the pre-implantation mouse embryo, which is located 
at the edge of the inner cell mass adjacent to the blastocoel (Plusa et al., 
2008).  
Yap was also expressed in the nuclei of cells located at the periphery of 
colonies (Figure 3.3A). Cells towards the centre of colonies exhibited a 
more diffuse Yap expression. This was not due to antibody penetration as 
co-staining using a pan-cadherin antibody displayed staining throughout 
the colony (Figure 3.3A). Expression of nuclear Yap in cells at the 
periphery of mESC colonies correlates with the expression of later marker 
of PrE, Gata4. This, together with increased expression of nuclear Yap in 
Gata6 positive cells raised the possibility that nuclear Yap may be 
associated with PrE cell fate. 
 
Figure 3.3. Nuclear Yap and Gata4 are expressed in cells located at the 
periphery of mESC colonies. (A) Representative confocal image of a colony 
IOUD2 cells stained for Topro3 (blue), Yap (green), and Pan-Cadherin (red) 
grown in KOSR with LIF (B) Representative confocal image of a colony of 
IOUD2 cells stained for Topro3 (blue), Gata4 (green), and Pan-Cadherin (red) 
grown in KOSR with LIF. Scale bar 50µm. Images shown are representative of 
five colonies from two independent experiments. 
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3.3 Embryoid	Bodies	as	a	model	of	PrE	differentiation	
The previous results suggest that Yap might be involved in PrE 
differentiation. Spontaneous differentiation towards PrE is a relatively rare 
event in mESCs. However aggregation of mESCs into embryoid bodies 
facilitates PrE differentiation (Hamazaki et al., 2004; Li & Yurchenco, 
2006). Embryoid bodies can recapitulate early steps of pre-implantation 
development, including differentiation of endoderm on the surface of the 
inner cell mass, differentiation of a columnar epithelium and subsequent 
formation of a central cavity (Coucouvanis & Martin, 1995).  
In order to study Yap in differentiation towards primitive endoderm, 
mESCs were cultured as embryoid bodies using two methods. In the first 
method, IOUD2 mESCs were cultured as aggregates in hanging drop 
suspension culture for 2 days and subsequently transferred into 
suspension culture for extended culture (Figure 3.4A). Presence of an 
endodermal outer layer was examined using phase contrast microscopy 
(Figure 3.4B). Even after 9 days in suspension culture, embryoid bodies 
formed using the hanging drop method did not appear to form an 




Figure 3.4. Culture of embryoid bodies in ‘hanging drop’ suspension 
culture. (A) Schematic illustrating culture of mESCs in hanging drop culture on 
lid of cell culture dish, prior to transfer to suspension culture. (B) Phase contrast 
images of Embryoid bodies at indicated time points. Scale bars 100µm.  
As no clear endoderm layer was formed using the ‘hanging drop’ method, 
a second method of forming embryoid bodies was used. IOUD2 mESCs 
were cultured as small cell clusters in suspension culture (Figure 3.5). 
After 3 days in culture, some embryoid bodies with a clear endodermal 
layer were visible (Figure 3.5B). After 4 days in culture these embryoid 
bodies would start to form a central cavity (Figure 3.5C) and could be 
could be maintained in culture for up to 7 days (Figure 3.5D-F). However 
efficiency of endodermal differentiation was low and many of the 




Figure 3.5. Culture of embryoid bodies in cell aggregate suspension 
culture. Phase contrast images of (A) initial cell clusters, Embryoid bodies after, 
(B) 3 days (white arrow indicates endodermal cells), (C) 4 days (Yellow arrow 
indicates formation of cavity), (D) 5 days, (E) 6 days and (F) 7 days in culture. 
Scale bars 100µm.  
Embryoid bodies that had formed a visible outer layer of endodermal cells 
were selected and expression of Yap was examined by immunostaining 
(Figure 3.6). The embryoid bodies were quite delicate and during the 
process of staining, cells on the surface would easily detach. However, 
strong nuclear staining could be seen in some cells on the outer surface 
(Figure 3.6A,B). Due to the low frequency of embryoid bodies forming an 
endodermal layer and the challenges in immunostaining it was not 
possible to examine whether the outer cells were expressing markers of 
primitive endoderm such as Gata4 and Gata6. Furthermore, as the 
frequency of embryoid bodies that formed a visible endoderm was low, 
the analysis of the expression of Yap in early events in differentiation 
could sadly not be monitored. 
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Figure 3.6. Yap is expressed in cells on the surface of embryoid bodies. 
(A) Confocal image of an embryoid body following 3 days in suspension culture 
stained for Topro3 (blue) and Yap (green). (B) Single confocal section of an 
embryoid body following 3 days in suspension culture stained for Yap (green). 
Optical orthogonal sections following the white lines in the main image are 
shown. White arrows indicate nuclear Yap expression. Scale bars: 100µm. 
3.4 Gata6-inducible	model	of	PrE	differentiation	
Differentiation of mESCs towards PrE-like cells can also be achieved 
through over-expression of Gata6 (Wamaitha et al., 2015). mESCs which 
express Gata6 under the control of a doxycycline-inducible promoter can 
be used to model the cell fate decision between PrE and Epiblast 
(Schröter et al., 2015). A short 6-hour pulse of doxycycline results in co-
expression of Gata6 and Nanog. Subsequent removal of doxycycline, 
followed by a chase period of 24 hours results in a resolution of cell fate 
decision with cells expressing either Gata6 or Nanog, which resemble 
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PrE or Epiblast cell fates respectively (Figure 3.7A,B). Pretreatment of 
these cells with the MEK inhibitor PD0325901 (hereafter referred to as 
PD) for 3 days enhances extra-embryonic differentiation potential 
(Schröter et al., 2015). This experimental model allows the analysis of 
mESCs before, during and after differentiation towards PrE like cells.  
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Figure 3.7. Gata6-inducible model of PrE differentiation. (A) Schematic 
indicating Gata6-inducible differentiation protocol. Cells initially express Nanog 
and following addition of doxycycline (Dox) for 6 hours cells co-express both 
Nanog and Gata6. Removal of doxycycline and culture for 24 hours in S+L 
media results in differentiation towards PrE-like cells expressing Gata6 or Epi 
like cells expressing Nanog. (B) Representative confocal images of Gata6-
inducible cells stained for Hoechst (blue), Gata6 (green) and Nanog (Magenta) 
grown in indicated conditions, Scale bar: 50µm. Images shown are 
representative of six independent experiments. 
To validate the experimental model, Gata6-inducible mESCs were treated 
with a 6-hour pulse of doxycycline and were then either fixed immediately 
or after a 24-hour chase in standard mESC culture media. These cells 
were then immunostained for Gata6 and Nanog and analyzed using 
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quantitative immunofluorescence. The nuclear Gata6 intensity of 
individual cells was plotted against its nuclear Nanog intensity so as to 
provide a graphical representation of the population of cells under each 
experimental condition (Figure 3.8). In order to define cells as positive or 
negative for Gata6 or Nanog, threshold intensities were created. 
Threshold intensity values were defined using mixture analysis (see 
Materials and Methods). Briefly, mixture analysis estimates the 
parameters of two or more distributions from pooled data; i.e. in this case 
the two distributions being Positive or Negative for Gata6 or Nanog. 
Mixture analysis was applied to the 24-hour chase, at which point cells 
express Gata6 and Nanog in a mutually exclusive manner. Intensities of 
Gata6 or Nanog above the threshold value were considered positive, and 
levels below threshold considered negative, therefore allowing four 
populations of cells in each experimental condition, Gata6-Nanog-, 
Gata6+Nanog+, Gata6+Nanog- and Gata6-Nanog+.   
As expected, in the untreated control almost all of the cells are negative 
for expression of Gata6, and positive for expression of Nanog i.e. Gata6- 
Nanog+ (Figure 3.8). Following a 6-hour pulse of doxycycline the majority 
of cells (78.76%) are co-expressing Gata6 and Nanog, i.e. 
Gata6+Nanog+. After a 24-hour chase a large proportion of cells are 
expressing either Gata6 or Nanog in a mutually exclusive manner, i.e. 
Gata6+Nanog- or Gata6-Nanog+, which represent cell fates of PrE or Epi 
respectively. The proportion of cells that express Gata6 following the 24-
hour chase resembles the proportion of cells that differentiate towards 
PrE in the ICM of the mouse embryo (Kang et al., 2012).  
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Figure 3.8. Quantitative analysis of Gata6 and Nanog expression in Gata6-
inducible model of PrE differentiation. Scatter plots showing Gata6 (x-axis) 
and Nanog (y-axis) nuclear intensity in fluorescence arbitrary units (AU) from 
immunostaining of Gata6-inducible cells in the indicated conditions. Each dot 
represents the levels in a single cell. Dashed lines represent threshold limits for 
Gata6 and Nanog. Bar charts indicate proportion of cells in each population. 
>597 cells were analysed in each culture condition. Data shown is 
representative of six independent experiments. 
3.5 Expression	of	Yap	in	Gata6-inducible	model	of	PrE	differentiation	
To investigate Yap regulation during differentiation towards PrE, nuclear 
Yap intensity was measured in the Gata6 inducible mESC model of PrE 
differentiation. Cells were treated with a 6-hour pulse of doxycycline and 
fixed either immediately or after a 24-hour chase in standard mESC 
culture media. These cells were then immunostained for Yap and 
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analyzed with quantitative immunofluorescence analysis (Figure 3.9). 
Immediately after a 6-hour pulse of doxycycline, nuclear Yap intensity 
was increased compared to an untreated control. Following a 24-hour 
chase, nuclear Yap Intensity decreased to levels below that of the 
untreated control (Figure 3.9). This shows that upon induction of Gata6, 
Yap is more abundant in the nucleus, and that upon differentiation, levels 
of Yap in the nucleus decrease.  
 
Figure 3.9. Nuclear Yap intensity increases following induction of Gata6. 
(A) Representative confocal images of Gata6-inducible cells stained for Hoechst 
(blue) and Yap (green) grown in indicated conditions, Scale bar: 50µm. (B) 
Distributions of Yap in Gata6-inducible cells cultured in S+L (blue line), Dox 6h 
(orange line) and Dox6h+24h (green line). (C) Box and whisker plot displaying 
intensity levels of Yap in indicated culture conditions. ****=P<0.0001 by one-way 
ANOVA and Tukey’s post-hoc test. n=at least 638 cells for each culture 
condition. Data shown is representative of two independent experiments. 
The specificity of the antibody (Cell Signalling 4912) used in these 
experiments has recently been called into question (Hirate et al., 2012; 
Saha, Home & Paul, 2012). In order to confirm the transient rise in Yap 
upon differentiation by induction of Gata6, the experiment was repeated 
with a separate Yap antibody from another supplier (Santa Cruz 15407). 
Using this second antibody, similar results were obtained whereby 
nuclear Yap intensity increased following induction of Gata6 expression, 
and decreased after the subsequent 24-hour chase (Figure 3.10). As 
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similar results were obtained with two separate antibodies, this suggests 
that Yap expression is indeed increased transiently upon induction of 
Gata6. The Yap antibody from Santa Cruz was used in preference in 
subsequent experiments.  
 
Figure 3.10. Increase in nuclear Yap is reproduced using the Santa Cruz 
Yap antibody  (A) Representative confocal images of Gata6-inducible cells 
stained for Hoechst (blue) and Yap (green) grown in indicated conditions, Scale 
bar: 50µm. (B) Distributions of Yap in Gata6-inducible cells cultured in S+L (blue 
line), Dox 6h (orange line) and Dox6h+24h (green line). (C) Box and whisker 
plot displaying intensity levels of Yap in indicated culture conditions. 
****=P<0.0001 by one-way ANOVA with Tukey’s post-hoc test. n=at least 748 
cells for each culture condition. Data shown is representative of five 
independent experiments. 
3.6 Expression	of	nuclear	Yap	is	associated	with	PrE	cell	fate		
As nuclear Yap intensity was increased in cells spontaneously 
differentiating towards PrE and also upon induction of Gata6, increased 
nuclear Yap may therefore be specifically associated with the PrE cell 
fate in mESCs. The Gata6 inducible cells provide an experimental model 
of cell fate choice between Gata6+Nanog- PrE and Gata6-Nanog+ Epi. 
To determine whether the increased nuclear Yap is associated with 
Gata6+Nanog- PrE like cell fate, Gata6 inducible cells were treated with a 
6-hour pulse of Doxycycline and fixed either immediately or after a 24-
hour chase period in standard mESC culture media. Nanog and Gata6 
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expression was determined using immunostaining along with Yap (Figure 
3.11) and analyzed by quantitative immunofluorescence (Figure 3.12). As 
previously shown in Figure 3.10, nuclear Yap intensity increased 
following a 6-hour pulse of doxycycline, and decreased following the 24-
hour chase period. 
 
Figure 3.11. Examining Yap expression in relation to cell fate. (A) 
Representative confocal images of Gata6-inducible cells stained for Hoechst 
(blue), Yap (white), Gata6 (green) and Nanog (magenta) grown in indicated 
conditions, Scale bar: 50µm. Images shown are representative of three 
independent experiments. 
The Gata6 nuclear intensity of individual cells was plotted against the 
Nanog nuclear intensity and the threshold intensities for Gata6 and 
Nanog were defined using mixture analysis. The nuclear intensity of Yap 
from individual cells was then plotted as a heat-map to give a graphical 
representation of Gata6, Nanog and Yap in individual cells (Figure 3.12A). 
As in Figure 3.7, after a 6-hour pulse of doxycycline, Gata6 and Nanog 
showed co-expression (Figure 3.12A). In mESCs cultured under these 
conditions, nuclear Yap intensity appears to be highest, and specifically in 
cells co-expressing Gata6 and Nanog (Figure 3.12B). Following the 24-
hour chase; Gata6 and Nanog were expressed in a mutually exclusive 
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manner representing PrE and Epi cell fates respectively. Nuclear Yap 
intensity is significantly higher in Gata6+Nanog- cells compared to Gata6-
Nanog+ cells (Figure 3.12C). This therefore suggests that PrE (and not 
Epi) cell fate is associated with increased nuclear Yap. 
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Figure 3.12: Quantitative analysis of nuclear Yap intensity in cell 
populations differentiating towards Epi or PrE cell fate (A) Scatter plots 
showing Gata6 (x-axis) Nanog (y-axis) and Yap (heat-map, side) nuclear 
intensity in fluorescence arbitrary units (AU) from immunostaining of Gata6-
inducible cells in the indicated conditions. Each dot represents the levels in a 
single cell. Dashed lines represent threshold limits for Gata6 and Nanog. Bar 
charts indicate proportion of cells in each population. (B,C) Box and whisker 
plots displaying intensity levels of Yap in indicated cell populations following (B) 
6 hours of doxycycline treatment and (C) 24 hours chase following 6 hours of 
doxycycline treatment. All populations in C are significantly different from each 
other. ***=P<0.001, ****=P<0.0001 by one-way ANOVA with Tukey’s post-hoc 
test. n=at least 294 cells for each culture condition. Data shown is 
representative of three independent experiments. 
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3.7 Hippo	regulation	of	Yap	during	PrE	differentiation	
Yap can be regulated by the Hippo signalling pathway through 
phosphorylation by Lats at S112 leading to interaction with 14-3-3 
proteins and cytoplasmic retention, thus rendering Yap unable to act as a 
transcriptional co-activator (Zhao et al., 2007). The previously observed 
increase in nuclear Yap upon differentiation towards PrE may therefore 
be a result of a decrease in phosphorylation at S112 by Lats allowing Yap 
to translocate to the nucleus.  Phosphorylation of Yap during 
differentiation towards PrE was measured using an antibody directed 
against pYap-S127 (Human Yap S127 is analogous to mouse Yap S112, 
hereafter referred to as pYap) (Figure 3.13A). Expression of pYap was 
quantified by fluorescence intensity profiles (Figure 3.13B). Expression of 
pYap did not appear to change following a 6-hour pulse of doxycycline 
(Figure 3.13A,B). This suggests that the increase in nuclear Yap 
expression upon differentiation may not be due to decreased 
phosphorylation and cytoplasmic retention. 24-hours after the pulse of 
doxycyxline, expression of pYap appeared reduced (Figure 3.13A,B). 
This is in accordance with the total expression level of Yap being 
decreased following differentiation. This experiment suggests that the 
observed increase in nuclear Yap expression upon differentiation towards 
PrE may not be due to decreased phosphorylation at YapS112. 
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Figure 3.13. Expression of pYap in Gata6 inducible model of PrE 
differentiation: (A) Representative confocal images of Gata6-inducible cells 
stained for Hoechst (blue) and pYap (green), grown in indicated conditions, 
Yellow lines indicate example intensity profiles. Scale bar: 50µm. (B) Bar chart 
displaying average fluorescence intensity, derived from intensity profiles. N.S.= 
no significant difference by one-way ANOVA with Tukey’s post-hoc test. n=3 
measurements per condition   
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3.8 Modulating	 subcellular	 localization	 of	 Yap	 through	 varying	
compliance	of	cell	culture	surface	
The subcellular localization of Yap has been shown to be regulated by 
stiffness of the extra-cellular matrix (Dupont et al., 2011). Culture of cells 
on stiff culture substrates (≥40kPa) results in expression of nuclear Yap, 
whereas culture of cells on soft substrates (0.7kPa) results in cytoplasmic 
retention of Yap (Dupont et al., 2011). This therefore presents the 
possibility of using soft culture substrates as a means to induce 
cytoplasmic retention of Yap and subsequently examine if differentiation 
of mESCs towards PrE is affected, due to the lack of Yap transcriptional 
activity. If nuclear Yap is required for differentiation towards PrE, 
preventing Yap translocating to the nucleus would inhibit differentiation 
towards PrE. 
To examine if compliance of the culture surface affects subcellular 
localization of Yap in mESCs, IOUD2 cells were cultured on 
polyacrylamide hydrogels of varying compliance (Figure 3.14). mESCs 
cultured on softer (0.7kPa) hydrogels appeared to form round colonies, 
whereas mESCs on hydrogels of increasing stiffness (4kPa, 40kPa) 
formed more irregular shaped colonies and showed more indication of 
cell spreading Figure 3.14.   
 
Figure 3.14. culture of mESCs on hydrogels of varying compliance. 
Representative phase contrast images of IOUD2 cells grown on polyacrylamide 
hydrogels. Approximate compliance is given in kPa. Scale bars 100µm 
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The subcellular localization of Yap in cells cultured on soft hydrogels was 
determined by immunostaining (Figure 3.15). Unfortunately, 
immunostaining of cells grown on hydrogels resulted in large amounts of 
non-specific staining (Figure 3.15), thus preventing analysis of the 
subcellular localization of Yap.  
 
Figure 3.15. Immunostaining of mESCs cultured on soft (0.7kPa) hydrogel. 
Representative confocal images of IOUD2 cells stained for Topro3 (blue) and 
Yap (Red). –ve control indicates no primary antibody. Scale bar: 10µm 
3.9 Small	molecule	 Inhibition	of	Yap	 in	Gata6	 inducible	model	of	PrE	
differentiation	
To examine if nuclear Yap is required for differentiation towards PrE, 
small molecules, dobutamine and verteporfin, were used to inhibit nuclear 
Yap. Dobutamine is a β-adrenergic receptor agonist which has been 
shown to induce phosphorylation and cytoplasmic retention of Yap (Bao 
et al., 2011). Verteporfin is a small molecule inhibitor, which binds to Yap, 
subsequently preventing its association with Tead transcription factors 
(Liu-Chittenden et al., 2012). If nuclear Yap is required for mESC 
differentiation towards PrE, inhibition of nuclear Yap through cytoplasmic 
retention, or inability to bind transcriptional co-activator Tead should 
prevent differentiation towards PrE. 
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The effect of these inhibitors on nuclear Yap was examined in the Gata6-
inducible model of PrE differentiation. Gata6-inducible mESCs were 
treated with a 6-hour pulse of doxycycline together with either 10µM 
dobutamine or 2.5µM verteporfin (Figure 3.16), as nuclear Yap 
expression was previously found to be highest following this time point. 
Addition of verteporfin resulted in widespread cell death, preventing 
further analysis (Figure 3.16). 
 
Figure 3.16. Inhibition of nuclear Yap with dobutamine and verteporfin: 
Representative phase contrast images of Gata6 inducible cells cultured under 
the indicated conditions. Scale bar: 50µm. Images shown are representative of 
two independent experiments. 
To investigate the effects of addition of dobutamine on cell fate choice, 
Gata6-inducible mESCs were treated with a 6-hour pulse of doxycycline 
together with dobutamine and fixed either immediately or following a 24-
hour chase in standard mESC culture media. Yap, Nanog and Gata6 
expression was determined using immunostaining (Figure 3.17A) and 
analysed by quantitative immunofluorescence. Addition of dobutamine 
during the 6-hour pulse of doxycycline significantly reduced nuclear Yap 
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expression compared to addition of doxycycline alone (Figure 3.17). 
Unexpectedly, addition of dobutamine resulted in expression of Nanog in 
both the nuclei and cytoplasm of cells.  
As increased nuclear Yap expression was previously found to be 
associated with PrE cell fate, Gata6 expression was examined 24-hours 
following the doxycycline pulse together with dobutamine. At this time 
point cells are either positive for Gata6 or Nanog. A threshold limit for 
Gata6 expression was defined by mixture analysis. Addition of 
dobutamine resulted in a decreased proportion of cells positive for Gata6 
expression compared to doxycycline alone (Figure 3.17C). This suggests 
that reduction of nuclear Yap expression results in fewer cells 




Figure 3.17. Dobutamine reduces nuclear Yap expression, which results in 
reduced Gata6 expression. (A) Representative confocal images of Gata6-
inducible cells stained for Hoechst (blue), Yap (white), Gata6 (green) and Nanog 
(magenta) grown in the indicated conditions, Scale bar: 50µm. (B) Box and 
whisker plot displaying intensity levels of Yap in indicated culture conditions. 
*=P<0.05, **=P<0.01 by one-way ANOVA with Tukey’s post-hoc test. n=at least 
294 cells per culture condition (C) Distributions of Yap in Gata6-inducible cells 
cultured in S+L (grey line), Dox 6h+24h (red line) and Dox+Dobu6h+24h 
(dashed blue line). Percentages of cells above Gata6 threshold limit are 
indicated. Data shown is representative of two independent experiments.  
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3.10 Summary	
• In mESCs, Nuclear Yap expression initially increases before 
decreasing upon differentiation induced by withdrawal of LIF 
• Nuclear Yap expression is increased in mESCs spontaneously 
differentiating towards PrE 
• Yap expression is high in endoderm-like cells on the surface of 
embryoid bodies 
• Gata6-inducible mESCs can model PrE cell fate choice 
• Nuclear Yap increases upon induction of Gata6 and is higher in 
cells that have differentiated towards PrE-like cell fate 
• Nuclear Yap increases upon induction of Gata6 is not associated 
with decreased pYap expression 
• Attenuation of Nuclear Yap with dobutamine resulted in a reduced 
proportion of cells differentiating towards PrE-like cell fate 
3.11 Discussion	
Nuclear	Yap	in	the	differentiation	of	mESCs	
In this Chapter it is shown that there is a decrease in total Yap expression 
upon differentiation of mESCs Figure 3.1. This is in agreement with 
previous studies (Tamm, Bower & Anneren, 2011; Lian et al., 2010). Here, 
in this Chapter, a more detailed analysis on Yap during differentiation is 
performed, showing an initial increase in nuclear Yap expression prior to 
differentiation, indicating dynamic regulation of Hippo signalling during 
this process (Figure 3.1). This initial increase in nuclear Yap expression 
may have been missed in the studies by Tamm et al. and Lian et al., due 
to the fact that only self-renewing conditions and end-points of 
differentiation were assayed. 
The same previous studies also highlight a potential role for Yap in the 
maintenance of mESC self-renewal, with Yap regulating the expression of 
Oct4 (Tamm, Bower & Anneren, 2011; Lian et al., 2010). A correlation in 
the behaviour of Oct4 and Yap can be seen in Figure 3.1, whereby upon 
induction of differentiation via the removal of LIF, an increase in both 
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Oct4 and Yap nuclear expression is observed. Despite its role in 
maintenance of pluripotency, Oct4 has also been shown to be required 
for differentiation in a number of contexts (Radzisheuskaya et al., 2013; 
Niwa, Miyazaki & Smith, 2000; Le Bin et al., 2014). ESCs and induced 
pluripotent stem cells (iPSCs) with lowered Oct4 levels maintain self 
renewal and fail to differentiate upon induction of differentiation cues 
(Radzisheuskaya et al., 2013), whilst over expression of Oct4 in ESCs 
leads to differentiation towards PrE (Niwa, Miyazaki & Smith, 2000). 
Deletion of Oct4 in the pre-implantation mouse embryo, induced during 
the transition from morula to blastocyst, results in cells of the inner cell 
mass failing to commit to either Epi or PrE lineages (Le Bin et al., 2014). 
It is thus apparent that Oct4 is required for exit from the pluripotent state, 
and the regulation of Oct4 by Yap could be involved in this context.  
Yap	in	differentiation	towards	PrE	
The results in this chapter show that differentiation towards PrE-like cell 
fate is accompanied by increased nuclear Yap expression (Figure 3.12). 
Nuclear Yap is increased in spontaneously differentiating mESCs that 
express Gata6, which is one of the earliest markers of PrE (Plusa et al., 
2008). This could suggest that Yap may be involved in early phases of 
PrE differentiation. Increased nuclear Yap expression was also observed 
in Gata6 expressing cells that had down regulated Nanog in the gata6-
inducible model of PrE differentiation (Figure 3.12) as well as in 
endodermal cells in embryoid bodies (Figure 3.6). This could suggest that 
increased nuclear Yap expression is also associated with maintenance of 
PrE cell fate. This could be confirmed by looking for expression of later 
markers of PrE such as Gata4 (Plusa et al., 2008), and seeing if nuclear 
Yap expression remains high in cells that express Gata4. Furthermore, 
the role of Yap in PrE differentiation can be assessed in vivo, by 
examination of Yap expression in the mouse pre-implantation embryo. 
Increase	in	nuclear	Yap	expression	following	induction	of	Gata6	
As induction of Gata6 resulted in increased expression of nuclear Yap 
(Figure 3.9 and Figure 3.10), it is possible that Gata6 is directly regulating 
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the expression of Yap. In a recent study by Wamaitha et al. Chromatin 
immunoprecipitation (ChIP) followed by high throughput sequencing 
(ChIP-seq) analysis of Gata6 binding targets, in a Gata6-inducible mESC 
line, did not identify Yap as a Gata6 bound region (Wamaitha et al., 2015). 
Furthermore, in the same study, RNA sequencing in a Gata6-inducible 
human embryonic stem cell line did not lead to an increase in expression 
of Yap RNA (Wamaitha et al., 2015). Taken together, these results from 
the study by Wamaitha et al. imply that upon induction of Gata6, Gata6 is 
not directly regulating expression of Yap.  
Regulation	of	Yap	by	Hippo	during	differentiation	towards	PrE	
If the increase of nuclear Yap expression is not due to an increase in 
expression of Yap, another possibility is that induction of Gata6 leads to 
decreased Hippo signalling, which results in decreased phosphorylation 
of Yap by Lats at YapS112. Phosphorylation of YapS112 results in 
cytoplasmic retention of Yap (Zhao et al., 2007), Thus, decreased Hippo 
signalling could result in increased nuclear Yap localization. 
Interestingly, immunostaining of pYap-S112 did not show decreased 
levels following 6-hours of doxycycline induced Gata6 expression (Figure 
3.13A,B). This suggests that increased nuclear levels of Yap at this time 
point is not due to decreased Yap S112 phosphorylation by Lats i.e. less 
cytoplasmic retention of Yap. This could therefore suggest that there may 
be more Yap protein in total due to either increased transcription of Yap, 
or increased stability of Yap. An increase in total Yap could potentially 
overcome Lats mediated phosphorylation and subsequent cytoplasmic 
retention. To test for an increase in expression of Yap, reverse 
transcriptase PCR could be used to detect an increase in Yap mRNA 
following induced expression of Gata6. If there is no increase in Yap 
mRNA then it is possible that the increased levels of nuclear Yap are due 
to increased Yap stability. This experiment was attempted, but due to the 
relatively low number of cells in the Gata6-inducible model of PrE 
differentiation assay, insufficient RNA was extracted for RT-PCR analysis. 
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It would be interesting to repeat this experiment, scaling up the amount of 
cells in the assay, such that sufficient RNA for analysis could be extracted.  
A recent study introduced a YapS112A knock-in mutation into the 
endogenous Yap locus, such that YapS112 cannot be phosphorylated by 
Lats and therefore evades cytoplasmic retention (Chen et al., 2015). The 
YapS112A mice appear phenotypically normal, which is surprising 
considering that they show nuclear localization of YapS112A, 
overexpression of which has previously been shown to induce aberrant 
tissue expansion (Camargo et al., 2007). The YapS112A mutant mice 
were found to be able to regulate the expression of Yap protein levels 
through increased phosphorylation by Lats of another serine residue 
YapS381 (Chen et al., 2015). Phosphorylation of YapS381 by Lats 
primes Yap for subsequent phosphorylation by Casein Kinase 1 (CK1), 
resulting in the generation of a ‘phosphodegron’, a motif that is 
recognised by β-transducin repeat-containing protein (β-TRCP) (Zhao et 
al., 2010). β-TRCP is an adaptor for SCF E3 ubiquitin ligases, which 
subsequently poly-ubiquitinates Yap, leading to its destruction by the 
proteasome (Zhao et al., 2010). Therefore in these mice, Yap 
transcriptional activity was regulated primarily through stability of the 
protein as opposed to its subcellular localisation. It is therefore possible 
that the transient increase in nuclear Yap upon induction of Gata6 is due 
to increased stability of Yap. To test this hypothesis, the half-life of Yap 
could be measured following induction of Gata6 by treatment with the 
inhibitor of protein synthesis, cycloheximide. Measuring the total amount 
of Yap following cycloheximide treatment could indicate if induction of 
Gata6 increases the stability of Yap.  
The half-life of Yap has been reported to be less than 3 hours in 
conditions that promote active Hippo signalling, such as high cell density 
(Levy et al., 2008; Zhao et al., 2010). The C-terminus of Yap contains a 
tyrosine residue, which upon phosphorylation by c-ABL, increases the 
stability of Yap (Levy et al., 2008). The same tyrosine residue has been 
reported to be phosphorylated by YES, downstream of LIF in mESCs, 
resulting in increased Yap dependent transcriptional activity (Tamm, 
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Bower & Anneren, 2011). It is therefore possible that Yap is stabilized 
downstream of LIF, allowing Yap to overcome Hippo mediated 
cytoplasmic retention. Interestingly, recent studies indicate a role for LIF 
in the expansion of PrE primed mESCs in cell culture, and the expansion 
of PrE cells in vivo (Morgani et al., 2013; Morgani & Brickman, 2015). 
Therefore it is possible to speculate that this LIF induced expansion of 
PrE is associated with increased nuclear Yap. Indeed, increased nuclear 
Yap is observed in mESCs spontaneously differentiating towards PrE in 
the presence of LIF (Figure 3.2). This is further evidence that increased 
nuclear Yap expression is associated with differentiation towards PrE, 
however the question remains; what is the function of nuclear Yap in 
relation to differentiation towards PrE? 
Nuclear	targets	of	Yap	
Increased nuclear Yap is associated with PrE differentiation in 
spontaneous differentiation (Figure 3.2), embryoid bodies (Figure 3.6) 
and in a Gata6 inducible model of differentiation (Figure 3.10). 
Furthermore inhibition of nuclear Yap resulted in a decreased proportion 
of cells differentiating towards PrE Figure 3.17, suggesting a requirement 
for nuclear Yap. In specification of the TE in the mouse pre-implantation 
embryo, nuclear Yap co-activates expression of TE specific transcription 
factors Cdx2 and Gata3 (Nishioka et al., 2009; Ralston et al., 2010). 
Interestingly, a recent study has shown that in embryonic pancreatic 
progenitor cells, Yap, Tead and Gata6 bind to enhancers of genes 
associated with pancreatic development, notably Hhex and Fgfr2 (Cebola 
et al., 2015). Hhex and Fgfr2 are associated with PrE development 
(Thomas, Brown & Beddington, 1998; Arman et al., 1998), which 
suggests the possibility that during differentiation, Yap acts with Gata6 to 
enhance transcription of endodermal associated targets. It would be 
interesting to examine transcriptional targets of Yap in mESCs 
differentiating towards PrE by methods such as ChIP-seq analysis.  
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Inhibition	of	Yap	during	PrE	differentiation	using	small	molecules	
In this Chapter, the small molecules dobutamine and verteporfin were 
used in order to inhibit nuclear Yap (Figure 3.16 &Figure 3.17). 
Unfortunately, due to time limitations, only one concentration of each was 
used in these experiments. In the case of verteporfin, a concentration of 
2.5µM resulted in cell death (Figure 3.16). The concentration of 2.5µM 
was chosen as this was shown to be the minimum concentration still able 
to provide >50% inhibition of Yap Tead interaction as measured by a 
Gal4-Tead reporter assay in HEK293 cells (Liu-Chittenden et al., 2012). 
The resulting cell death in mESCs could suggest a role for Yap and Tead 
in cell survival, however it could also be a result of concentration 
dependent non-specific activity of verteporfin. Examining the effects of 
lower concentrations of verteporfin in mESCs would provide insight into 
this matter. 
The other small molecule used to inhibit nuclear Yap was the β-
adrenergic receptor agonist dobutamine Figure 3.17. Treatment with 
dobutamine reduced the increase in nuclear Yap expression upon 
induction of Gata6 (Figure 3.17B), which resulted in a decreased 
proportion of cells differentiating towards PrE (Figure 3.17C). This is in 
accordance with Yap being required for differentiation towards PrE. 
Interestingly, treatment with dobutamine for 6 hours resulted in an 
increase in Nanog expression, in both the nucleus and cytoplasm. It is a 
possibility that due to reduced nuclear Yap, Gata6 repression of Nanog is 
impaired, resulting in excess Nanog protein in the cell. However there is 
also the possibility that this observed affect on Nanog is due to unknown 
downstream mechanisms of the β-adrenergic receptor. Indeed, the exact 
mechanisms resulting in the increased phosphorylation of Yap 
downstream of dobutamine activation of the β-adrenergic receptor is 
unknown. 
To examine if Yap is absolutely required for PrE differentiation, the effect 
of a knockout of Yap in the Gata6 inducible cells could be examined. If 
Yap is required for PrE differentiation, knockout of Yap would prevent PrE 
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differentiation upon induction of Gata6. Furthermore, this would rule out 
the possibility of off target effects as seen with the use of small molecules. 
Conversely, it would be interesting to see if increasing nuclear Yap 










During mouse pre-implantation development, two key cell fate decisions 
occur. The first takes place after compaction, around embryonic day 3 
(E3.0) of development, where the trophectoderm (TE) and the inner cell 
mass (ICM) are specified. The TE is an extra-embryonic lineage, which 
will form the foetal portion of the placenta (reviewed in Schrode et al., 
2013). The Hippo signalling pathway has been shown to be important in 
specification of the TE (Nishioka et al., 2008; 2009). Cells from the ICM 
exhibit increased Hippo signalling, leading to increased phosphorylation 
and subsequent cytoplasmic retention of Yap (Nishioka et al., 2009). In 
contrast, the polarized outer cells exhibit decreased Hippo signalling, 
which results in increased nuclear Yap expression, leading to increased 
Tead4-dependent transcription of Cdx2, a TE specific transcription factor 
(Nishioka et al., 2009).  
The second cell fate choice occurs around E3.5, when cells of the ICM 
separate into two populations, primitive endoderm (PrE) and epiblast 
(Epi). The PrE will contribute to extra-embryonic membranes such as the 
parietal and visceral endoderm of the yolk sac and the Epi will give rise to 
the embryo proper (reviewed in Schrode et al., 2013). Initially, all cells of 
the ICM co-express the transcriptional regulators Gata6 and Nanog, 
which are markers of PrE and Epi respectively. Around E4.0, as the 
embryo develops, expression of Gata6 and Nanog becomes mutually 
exclusive, forming a “salt and pepper” expression pattern. These cells 
then undergo sorting, where the Gata6-expressing PrE precursors 
migrate towards the surface of the ICM, in contact with the blastocoel of 
the blastocyst, where they will form the PrE. PrE precursor cells that do 
not reach the blastocoel will undergo apoptosis or downregulate PrE 
gene expression and contribute to the epiblast(Plusa et al., 2008; Saiz et 
al., 2013; Chazaud et al., 2006). Positional cues are therefore important 
for the proper formation of the PrE. As positional cues direct Hippo 
signalling in the differentiation of the TE (Nishioka et al., 2009), it is 
possible that Hippo signalling also has a role in the formation of the PrE. 
However, this possibility has currently not been explored. 
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4.2 Yap	is	expressed	in	the	nuclei	of	primitive	endoderm	cells	
To investigate the role of Yap in the differentiation of PrE and Epi, 
localization of Yap was examined by immunostaining embryos from E3.0 
to E4.5 with a polyclonal Yap antibody (Santa Cruz 15407) (Figure 4.1 & 
Figure 4.2). Yap was found to be expressed in the nuclei of outer cells of 
morulae and in the TE of early blastocysts, as previously described 
(Figure 4.1)(Nishioka et al., 2009). However, Yap was also clearly 
detected in the nuclei of inner cells in these embryos, albeit at a lower 
level. Recently Home et al. reported that Yap was consistently nuclear in 
both inner and outer cells, using an antibody from Cell Signalling (Home 
et al., 2012). However, the signal observed using the Cell Signalling 
antibody was shown to be present in Yap-/- embryos, suggesting that it is 
a non-specific artefact of the antibody (Hirate et al., 2012). In order to 
confirm that Yap expression was higher in the outer cells compared to 
inner cells, E3.0 and E3.5 embryos were analysed using a software tool 
called Modular Interactive Nuclear Segmentation (MINS). Using MINS, 
inner and outer cells were classified automatically based on distance from 
the centre of the embryo. These classifications were confirmed manually 
and mean nuclear Yap intensity was determined (Figure 4.1A). Mean 
nuclear Yap intensity was found to be significantly higher in outer cells 
compared to inner cells (Figure 4.1B). This confirms that the antibody 
used for experiments in this chapter (Santa Cruz 15407) yields similar 
results as those described by Nishioka et al.  
In mid to late blastocysts, Yap was expressed in nuclei of TE cells and 
diffusely throughout cells of the ICM (Figure 4.2). In E4.5 embryos, when 
the Gata6-positive cells have segregated and formed the PrE, Yap was 
highly expressed in the nuclei of cells forming the PrE, with low 
expression in cells of the Epi (Figure 4.2, bottom row). In summary, this 
data shows that Yap is expressed in the nuclei of cells that form the TE 
and in cells of the PrE following segregation. These observations are in 
agreement with a previous study of Yap in mouse pre-implantation 
embryos (Frankenberg et al., 2013). Altogether this suggests that Yap 
may be involved in the lineage commitment of PrE 
 75 
 
Figure 4.1. Nuclear Yap is more highly expressed in outer cells compared 
to inner cells, (A) Representative confocal section of mouse pre-implantation 
embryos at E3.0 and E3.25 immunostained for Yap (red). Total cell number is 
displayed for each embryo shown. Dashed white lines indicate inner cells. Scale 
bar: 50µm. (B) Box and whiskers plot displaying nuclear Yap intensity, Solid line 
indicates median values, while cross indicates mean value. ****=P<0.0001 by 
Students unpaired t-test. n= 394 cells from 9 embryos. 
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Figure 4.2. Yap is expressed in the nuclei of PrE cells at E4.5, 
Representative confocal sections of mouse embryos at successive stages of 
pre-implantation development, immunostained for Nanog (magenta), Gata6 
(green) and Yap (red). Embryonic Day (E) with total cell number for each 
embryo is shown. Scale bar: 50µm.   
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4.3 Nuclear	Yap	expression	in	PrE	Precursors			
The expression of Yap in the nuclei of PrE cells of E4.5 embryos may 
indicate a potential role for Yap in PrE specification. To determine if Yap 
is involved in specification of PrE, cells of the ICM of E3.5-E4.5 embryos 
were examined in more detail, using quantitative image analysis. Mouse 
embryos were collected at E3.5 and E4.5 and immunostained for Yap, 
Gata6 and Nanog. The total cell number and the expression of Gata6 and 
Nanog were used to classify embryos into the developmental time points 
E3.5 (32-60 cells), E4.0 (60-120 cells) and E4.5 (>120 cells) (Figure 4.3).  
 
Figure 4.3. Classification of embryos into developmental time points 
based on total cell number, Representative confocal sections of mouse pre-
implantation embryos at E3.5, E4.0, E4.5 immunostained for Gata6 (green) and 
Nanog (magenta). The images illustrate the initial co-expression (left panel), 
then salt and pepper pattern (middle panel) and eventual sorting of Gata6 and 
Nanog expression into separate populations (right panel). These developmental 
time points were classified by total cell number by the ranges indicated in the 
main text. 
Fluorescence intensities were measured by quantitative 
immunofluorescence following segmentation of cell nuclei with MINS. In 
order to classify cells as positive or negative for Gata6 or Nanog, 
threshold intensities were defined. Threshold intensity values were 
defined using mixture analysis applied to intensity values from E4.5 
embryos, as at this stage cells are in clear populations expressing either 
Gata6 or Nanog (see Materials and Methods). Intensities of Gata6 or 
Nanog above the threshold value were considered positive, and levels 
below threshold considered negative, therefore four populations of cells 
at each embryonic stage could be defined: Gata6-Nanog-, 
Gata6+Nanog+, Gata6+Nanog- and Gata6-Nanog+. The nuclear Gata6 
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intensity of individual cells of the ICM was then plotted against its nuclear 
Nanog intensity so as to provide a graphical representation of the 
population of cells at each embryonic stage (Figure 4.4, Figure 4.5 and 
Figure 4.6).  
In E3.5 embryos Gata6 and Nanog are co-expressed (Figure 4.4A,B). 
Although Yap was occasionally expressed in the nuclei of cells in the ICM, 
no significant difference in mean nuclear Yap intensity was found 
between populations (Figure 4.4A,C). In E4.0 embryos, Gata6 and Nanog 
are expressed in a “salt and pepper” manner in the ICM (Figure 4.5A,B). 
Mean nuclear Yap intensity was found to be higher in Gata6+Nanog+ 
cells compared to Gata6-Nanog+ cells (Figure 4.5C). In E4.5 embryos, 
Gata6 and Nanog are expressed in the PrE and Epi respectively. Yap 
was expressed in the nuclei of cells that formed the PrE (Figure 4.6A,B) 
and mean nuclear Yap was significantly increased in Gata6+Nanog- cells 
of the PrE as compared to Gata6-Nanog+ cells of the Epi (Figure 4.6C).  
In summary, quantitative analysis of nuclear Yap intensity across the 
developmental time points examined appears to show that when cells 
begin to specify fate i.e. when cells begin to express either Gata6 or 
Nanog, nuclear Yap intensity is higher in cells expressing Gata6. This 
suggests that Yap may be involved in initial specification of PrE 
precursors as well as lineage commitment.  
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Figure 4.4. Quantification of Yap expression in E3.5 embryos, (A) 
Representative confocal section (upper row) and maximum projection (lower 
row) of mouse pre-implantation embryos at E3.5 immunostained for Nanog 
(magenta), Gata6 (green) and Yap (red). Arrow indicated ICM cell expressing 
nuclear Yap. Scale bar: 50µm. (B) Scatter plots showing Gata6 (x-axis), Nanog 
(y-axis) and Yap (heat map, side bar) nuclear intensity in fluorescence arbitrary 
units (AU). Each dot represents the levels in a single cell. Dashed lines 
represent threshold limits for Gata6 and Nanog (C) Box and whisker plots 
displaying intensity levels of Yap in defined populations. Solid line indicates 
median values, while cross indicates mean value. Bar chart to the right indicates 
proportion of cells in each population. 72 cells were analysed from 4 embryos. 
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Figure 4.5. Quantification of Yap expression in E4.0 embryos, (A) 
Representative confocal section (upper row) and maximum projection (lower 
row) of mouse pre-implantation embryos at E4.0 immunostained for Nanog 
(magenta), Gata6 (green) and Yap (red). Scale bar: 50µm. (B) Scatter plots 
showing Gata6 (x-axis), Nanog (y-axis) and Yap (heat map, side bar) nuclear 
intensity in fluorescence arbitrary units (AU). Each dot represents the levels in a 
single cell. Dashed lines represent threshold limits for Gata6 and Nanog (C) Box 
and whisker plots displaying intensity levels of Yap in defined populations. Solid 
line indicates median values, while cross indicates mean value. Bar chart to the 
right indicates proportion of cells in each population. *=P<0.05 by one-way 
ANOVA with Tukey’s post-hoc test. n=66 cells from 3 embryos. 
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Figure 4.6. Quantification of Yap expression in E4.5 embryos, (A) 
Representative confocal section (upper row) and maximum projection (lower 
row) of mouse pre-implantation embryos at E4.5 immunostained for Nanog 
(magenta), Gata6 (green) and Yap (red). Scale bar: 50µm. (B) Scatter plots 
showing Gata6 (x-axis), Nanog (y-axis) and Yap (heat map, side bar) nuclear 
intensity in fluorescence arbitrary units (AU). Each dot represents the levels in a 
single cell. Dashed lines represent threshold limits for Gata6 and Nanog (C) Box 
and whisker plots displaying intensity levels of Yap in defined populations. Solid 
line indicates median values, while cross indicates mean value. Bar chart to the 
right indicates proportion of cells in each population. **=P<0.001, ***=P<0.0001 




Yap can be regulated by the Hippo signalling pathway through 
phosphorylation at S112. Phosphorylation of Yap at S112 leads to the 
creation of a 14-3-3 binding site allowing Yap to bind to 14-3-3 proteins 
(Basu et al., 2003). 14-3-3 proteins retain Yap in the cytoplasm thus 
rendering Yap unable to act as a transcriptional co-activator (Zhao et al., 
2007). In order to examine if increased nuclear Yap in cells expressing 
higher levels of Gata6 is due to decreased Hippo signalling activity 
resulting in rescued cytoplasmic retention of Yap, E3.5 and E4.5 embryos 
were immunostained with an antibody directed against pYap-S127 
(Figure 4.7A) (Human Yap S127 is analogous to mouse Yap S112, 
hereafter referred to as pYap). Visually in E3.5 embryos, pYap 
expression was higher in the cytoplasm of cells of the ICM compared to 
outer cells that form the TE. In E4.5 embryos, pYap expression was also 
higher in the cytoplasm of cells of the ICM compared to cells of the TE. 
There was no visible decrease in cytoplasmic pYap expression in Gata6-
expressing cells that form the PrE in E4.5 embryos. To quantify the 
immunostaining, fluorescence intensity profiles were created using Gata6 
as a marker of PrE (Figure 4.7B). Intensity profiles revealed that 
expression of pYap is not significantly different between cells of the PrE 
and the Epi (Figure 4.7C). This suggests that the increase of nuclear Yap 
observed in cells expressing higher levels of Gata6 is not due to 
decreased cytoplasmic retention of Yap. pYap staining was visible in 
nuclei of cells expressing Gata6. However, this could potentially be the 
result of antibody cross reactivity, as pYap is generally expected to be 
excluded from the nucleus, and Nishioka et al. did not observe nuclear 
staining of pYap in E3.0 mouse embryos (Nishioka et al., 2009).  
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Figure 4.7. Expression of pYAP in E3.5 and E4.5d embryos. (A) 
Representative confocal sections of mouse pre-implantaion embryos at E3.5 
and E4.5 immunostained for pYap (green) and Gata6 (red). Dashed white lines 
indicate inner cell mass. Arrows indicate example of nuclear pYap. Scale bar: 
50µm. (B) Quantification of cytoplasmic pYap in E4.5. Fluorescence intensity 
profiles along the lines drawn either through PrE or Epi. (C) Bar chart comparing 
average intensity from n=3 measurements from one embryo. Bar chart displays 
mean ± standard error of the mean. 
4.5 Culture	of	mouse	pre-implantation	embryos	with	inhibitors	of	Yap	
leads	to	a	decrease	in	Gata6	expression	
To test if Yap is important in the specification of PrE, embryos were 
cultured with inhibitors of Yap during the time period in which this process 
occurs. E3.5 embryos can be cultured in vitro, during which time 
patterning of the embryo will still occur (Dietrich & Hiiragi, 2007). In order 
to inhibit Yap, dobutamine, a β-adrenergic agonist that has been shown 
to induce phosphorylation and cytoplasmic retention of Yap (Bao et al., 
2011), and verteporfin, a small molecule that inhibits Tead-Yap binding 
(Liu-Chittenden et al., 2012) were used. Dobutamine was used at a 
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concentration of 10µM as this was found to reduce nuclear Yap 
expression in mESCs in the previous Chapter. Verteporfin was used at 
2.5µM as this concentration has been reported to reduce expression of 
Cdx2 in early mouse embryos (Rayon et al., 2014). E3.5 embryos were 
cultured in the absence or presence of dobutamine or verteporfin for 24 
hours (Figure 4.8). Control embryos cultured in KSOM for 24 hours had 
expanded and formed blastocoels. In comparison, embryos cultured with 
dobutamine had not expanded as much as the control embryos. Culturing 
embryos with verteporfin lead to widespread cell death, precluding further 
analysis.  
 
Figure 4.8. Culture of E3.5 embryos with inhibitors of Yap, Bright field 
images of E3.5 embryos following 24h culture in KSOM, Dobutamine 10µM 
(Dobu) or Verteporfin 2.5 µM (Verte). Scale bar: 100µm. 
To examine the effect of dobutamine on specification of PrE and Epi 
lineages, the proportion of ICM cells expressing Gata6 or Nanog was 
determined. Control and dobutamine treated embryos were fixed and 
immunostained for Yap, Gata6 and Nanog (Figure 4.9A). Embryos were 
analysed using MINS in order to determine expression levels in individual 
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cells. Dobutamine treatment of embryos appeared to reduce nuclear Yap 
intensity with fewer cells displaying high Yap levels (Figure 4.9A,B,C) 
Although this difference was not statistically significant, it suggests that 
Dobutamine treatment results in cytoplasmic retention of Yap (Figure 
4.9C).  The nuclear Gata6 intensity of individual cells of the ICM was 
plotted against its nuclear Nanog intensity so as to provide a graphical 
representation of the population of cells (Figure 4.9B). To classify cells as 
positive or negative for Gata6 or Nanog, threshold intensities were 
defined, using mixture analysis on intensity values from control embryos. 
Treatment with dobutamine appeared to reduce the proportion of cells 
that are positive for expression of both Gata6 and Nanog (Figure 4.9B). 
Indeed the mean nuclear intensity of Gata6 and Nanog for cells in the 
ICM was found to be significantly lower in dobutamine treated embryos, 
compared to control embryos (Figure 4.9D and E respectively).  
To assess if treatment of embryos with dobutamine was affecting growth 
and survival of cells, the number of cells in the blastocyst compartments 
was determined. No significant difference was found between the number 
of cells comprising the ICM in control and dobutamine-treated embryos. 
This result suggests that treatment with dobutamine does not affect 
growth of the ICM. However, a significant decrease was observed in the 
number of TE cells in dobutamine-treated embryos compared to control 
embryos. This suggests that dobutamine may inhibit growth of the TE.  
In summary, these results suggest that treatment of embryos with 
dobutamine results in decreased expression of both Gata6 and Nanog in 
the cells of the ICM. Growth of the ICM is not affected by dobutamine 
treatment. However a reduction in TE cell number is observed. The 





Figure 4.9: Dobutamine treatment of E3.5 embryos leads to decreased 
expression of Gata6 and Nanog and a reduction in TE cell number, (A) 
Representative confocal sections of embryos cultured for 24 hours in either 
KSOM or KSOM+Dobutamine 10µM, Scale bar: 50µm (B) Scatter plots showing 
Gata6 (x-axis), Nanog (y-axis) and Yap (heat map, side bar) nuclear intensity in 
fluorescence arbitrary units (AU) in KSOM  (upper graph) or dobutamine treated 
embryos (lower graph). Each dot represents the levels in a single cell. Dashed 
lines represent threshold limits for Gata6 and Nanog with bar charts indicating 
proportion of cells in each population. (C,D,E) Box and whisker plots displaying 
intensity levels of Yap(C), Gata6(D) and Nanog(E) in KSOM and Dobutamine 
treated embryos respectively. Solid line indicates median values, while cross 
indicates mean value. *=P<0.05, ****=P<0.0001 by Students unpaired t-test. 
n=155 cells from 10 KSOM treated embryos and 194 cells from 10 Dobutamine 
treated embryos. (F) Box and whisker plot displaying cell counts of ICM and TE 
lineages upon treatment with dobutamine. *=P<0.05, Students unpaired t-test. 
10 embryos were analysed per culture condition. 
4.6 Summary	
In this Chapter, mouse pre-implantation embryos from E3.5 to E4.5 were 
immunostained in order to examine expression of Yap in the cell fate 
decision between PrE and Epi. Nuclear Yap intensity was found to be 
higher in Gata6+Nanog- cells of the PrE compared to Gata6-Nanog+ 
cells of the Epi. Although nuclear Yap intensity was increased, this did not 
appear to be due to decreased Hippo-dependent phosphorylation of 
YapS127. Treatment of embryos with dobutamine resulted in decreased 
expression of Gata6 and Nanog, and a reduction in TE cell number. 
4.7 Discussion	
Yap	in	specification	of	PrE	
During amniotic development, formation of the primitive endoderm is an 
important event in order to generate extra-embryonic tissues (as 
reviewed in Schrode et al., 2013). Separation of pluripotent epiblast cells 
and PrE precursors occurs through active cell sorting, with PrE 
precursors moving towards the blastocoel. Cells that remain misplaced 
undergo selective apoptosis, which suggests the possibility of a 
mechanism in which cells can sense their position in order to ensure the 
correct placement of PrE and Epi cells. 
The results in this Chapter show that Yap is expressed in nuclei of cells of 
the PrE at E4.5 (Figure 4.2). This observation may suggest that, following 
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sorting of cells, polarization of PrE cells located adjacent to the blastocoel 
leads to inhibition of Hippo signalling, thus allowing un-phosphorylated 
Yap to translocate to the nucleus. Indeed it has been shown that at E4.5, 
atypical protein kinase C (aPKC), a protein involved in apicobasal polarity, 
is polarised apically on the surface of PrE cells (Saiz et al., 2013). aPKC 
has been shown to inhibit Hippo signalling in TE specification, allowing 
Yap to translocate to the nucleus in outer, polarised cells of the embryo 
(Hirate et al., 2013). Therefore nuclear localization of Yap in the PrE of 
E4.5 embryos may be downstream of polarization. Disruption of this 
polarization using inhibitors of aPKC results in apoptosis of PrE cells, 
despite the correct localization, suggesting that cells are unable to 
perceive positional information (Saiz et al., 2013). It is tempting to 
speculate that Yap is therefore involved in the protection of correctly 
positioned PrE cells from apoptosis, such that misplaced cells expressing 
PrE markers do not polarize and subsequently do not inactivate Hippo 
signalling. 
Although Yap was found predominantly nuclear in the PrE at E4.5, 
nuclear Yap was also seen in cells of the ICM at earlier stages, with 
higher nuclear Yap in cells expressing higher levels of Gata6 (Figure 4.5). 
This could indicate that Yap also has a function in the initial specification 
of PrE cells. Following co-expression in the ICM of E3.5 embryos, cells 
down-regulate expression of either Gata6 or Nanog leading to a “salt and 
pepper’ expression pattern of lineage markers (Chazaud et al., 2006; 
Plusa et al., 2008). FGF signalling has been shown to be instrumental in 
this specification through up-regulation of Gata6 and down-regulation of 
Nanog (Chazaud et al., 2006; Kang et al., 2012; Yamanaka, Lanner & 
Rossant, 2010; Nichols et al., 2009; Bessonnard et al., 2014). Ras, a 
small GTPase downstream of FGF receptor, has been shown to promote 
Yap stability through down-regulation of the ubiquitin ligase complex 
substrate recognition factors SOCS5/6 (Hong et al., 2014). This raises 
the possibility that, in cells of the ICM, FGF signalling enhances the 
stability of Yap, thus leading to increased levels of Yap in the cell. 
Increased levels of Yap could subsequently overcome Hippo-dependent 
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phosphorylation and cytoplasmic retention, therefore entering the nucleus 
and exerting a transcriptional effect.   
siRNA knockdown of TEAD4 in cells of the ICM has been shown to lead 
to a bias towards Epi cell fate choice (Mihajlović, Thamodaran & Bruce, 
2015). This is in accordance with the findings described here, in that 
increased nuclear Yap is associated with PrE, thus loss of the 
transcription factor with which Yap binds prevents PrE specification. 
Tead4 has been shown, via CHIP-Seq, to bind to the proximal promoter 
regions of Fgfr2, Dab2 and Lrp2 in trophoblast stem cells (Home et al., 
2012). In accordance with this result, clonal knockdown of TEAD4 in cells 
of the ICM was shown to result in reduced expression of Fgfr2 (Mihajlović, 
Thamodaran & Bruce, 2015). Yap may therefore have a role in reinforcing 
PrE cell fate specification in a positive feedback mechanism, in which 
activation of Fgfr2 results in increased stability of Yap, which in turn leads 
to increased expression of Fgfr2. 
Derivatives of the PrE will form the yolk sac of the embryo, and are also 
important for induction of signals in the adjacent embryonic tissue, 
particularly in the establishment of the anterior-posterior axis (Thomas & 
Beddington, 1996; Varlet, Collignon & Robertson, 1997). Interestingly, 
mice carrying a targeted disruption of the Yap gene undergo 
developmental arrest at E8.5, revealing defects in yolk sac 
vasculogenesis, and a shortened body axis. These observations can be 
explained by an earlier requirement for Yap during formation of the PrE, 
which is supported by the data presented here. It would be interesting to 
see if specification of the PrE in Yap-/- embryos is disrupted. 
Hippo	regulation	of	Yap	during	specification	of	PrE	
Despite increased nuclear Yap expression in cells of the PrE compared to 
Epi in E4.5 embryos, no difference was observed in cytoplasmic pYap 
(Figure 4.7C). Phosphorylation of YapS112 results in binding to 14-3-3 
proteins and cytoplasmic retention (Zhao et al., 2007). This may suggest 
that the increased nuclear Yap is not a result of decreased Hippo 
dependent cytoplasmic retention. Yap can also be regulated by 
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phosphorylation at S381, which results in subsequent ubiquitination and 
degradation of Yap (Zhao et al., 2010). The increased nuclear Yap 
expression in PrE may therefore be due to increased stability of Yap 
allowing Yap to overcome Hippo dependent cytoplasmic retention. 
Disruption of upstream Hippo signalling components also leads to defects 
in formation of the PrE. Loss of the Hippo pathway member 
neurofibromain 2 (Nf2, orthologue of Drosophila Merlin), leads to loss of 
PrE formation (McClatchey et al., 1997). As Hippo pathway members are 
negative regulators of Yap, this would suggest that increased nuclear Yap 
is not involved with PrE formation. However, subsequent studies into loss 
of Hippo pathway members Nf2 or Lats show that cells of the ICM mis-
express the TE marker Cdx2 (Hirate et al., 2013; Cockburn et al., 2013; 
Lorthongpanich et al., 2013). Aberrant expression of Cdx2, along with 
Gata6 and Nanog in the ICM may result in incompatible developmental 
programs, or inhibition of the proper specification of PrE and Epi lineages. 
Consequently, the loss of PrE following ablation of upstream Hippo 
pathway members may be due to ectopic expression of Cdx2 in the ICM. 
Therefore it is important to allow correct specification of TE and ICM 
before studying the effects of loss of Yap or Hippo pathway members on 
PrE specification.  
Inhibition	of	Yap	during	specification	of	PrE		
In this chapter, two small molecules, dobutamine and verteporfin, were 
used in an attempt to inhibit the nuclear effect of Yap during specification 
of PrE. Treatment with Verteporfin resulted in embryonic cell death, which 
could suggest an important role for Yap-Tead binding in cell growth and 
survival during pre-implantation development. However, the observed cell 
death could also be the result of non-specific effects of verteporfin. 
Verteporfin has been used previously to inhibit Yap-Tead interactions 
during specification of TE in mouse embryos, resulting in a reduction of 
Cdx2 expression (Rayon et al., 2014). The same concentration of 
verteporfin used by Rayon et al. was used in the experiments in this 
 91 
chapter. It would be interesting to see if lower concentrations of 
verteporfin were still cytotoxic. 
Treatment with dobutamine resulted in a reduction in expression of Gata6 
and Nanog in cells of the ICM. Dobutamine is a β-adrenergic receptor 
agonist, which has been shown to induce phosphorylation and 
subsequent cytoplasmic retention of Yap, although the exact mechanism 
of action is unknown (Bao et al., 2011). The results in this chapter may 
therefore suggest that nuclear Yap expression is required for correct 
segregation of PrE and Epi lineages. However, this experiment did not 
determine whether treatment with dobutamine prevents correct cell fate 
specification, only that expression of Gata6 and Nanog are reduced. In 
order to examine if dobutamine prevents cell fate specification, later 
markers of PrE could be used for example Sox7, which is expressed only 
following sorting of PrE precursor cells (Artus, Piliszek & Hadjantonakis, 
2011).  
ICM cell number was not affected by dobutamine treatment, however a 
decrease in TE cell number was observed. As Yap is required for 
specification of TE and is shown here to be expressed in the nuclei of TE 
cells throughout pre-implantation development (Figure 4.2), this may 
suggest that nuclear Yap is required for growth of TE cells.  
Although a decrease in nuclear Yap intensity was observed following 
treatment of embryos with dobutamine for 24 hours, this decrease was 
not found to be statistically significant. It is possible that the effects of 
dobutamine were transient, and that fixation after 24 hours had missed 
the maximum reduction in nuclear Yap. To determine if this is the case, a 







Chapter 5:  Creation of an inducible knockout of 




Yap is believed to have a critical role in the maintenance of self-renewal 
and pluripotency in mouse embryonic stem cells (mESCs) (Tamm, Bower 
& Anneren, 2011; Lian et al., 2010). Tamm et al. report that Yap 
increases the activity of Oct4 and Nanog promoters downstream of LIF, 
whereas Lian et al. report that ectopic expression of Yap induces 
expression of Oct4 and Sox2 (Tamm, Bower & Anneren, 2011; Lian et al., 
2010). However, the results obtained in the previous chapters show a 
requirement for increased nuclear Yap upon differentiation towards 
primitive endoderm (PrE) implying that the absence of Yap in mouse 
embryonic stem cells (mESCs) would favour stable pluripotency. 
Therefore, ablation of Yap in mESCs would provide a model system in 
which to assess the importance of Yap in maintenance of self-renewal 
and pluripotency in mESCs.   
Ablation of a gene and observing the effects is one of the most direct 
methods to study the function of a gene. Embryonic stem cells can be 
genetically modified through homologous recombination (Thomas & 
Capecchi, 1987). This method involves the introduction of genomic DNA 
into a cell, whereby it can recombine into its corresponding genomic locus. 
Addition of a selectable marker, for example resistance to an antibiotic, 
allows for positive selection of cells in which recombination has occurred. 
Targeting of the selectable marker into an essential part of the gene of 
interest leads to creation of a null allele, i.e. an allele that cannot produce 
a functional protein (Figure 5.1). In order to generate a homozygous 
mutant, both alleles need to be targeted.  
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Figure 5.1. Genome editing via homologous recombination. Schematic 
illustrating homologous recombination. The homology arms on the targeting 
vector recombine with the endogenous locus resulting in insertion of a neomycin 
(neo) selectable marker. Dashed lines represent mRNA transcription. 
Bi-allelic mutations can be generated in a variety of ways. A common 
method is to target each allele sequentially, using targeting vectors with 
different selectable markers, thus allowing selection of cells that carry a 
mutation in both alleles (Riele et al., 1990). An alternative method relies 
on loss of heterozygosity, whereby following targeting of one allele, cells 
spontaneously duplicate the selectable marker, thus losing the remaining 
wild-type allele (Mortensen et al., 1992). These cells therefore express 
double the amount of selectable marker and can be selected using 
increasing concentrations of the appropriate antibiotic (Mortensen et al., 
1992; Lefebvre et al., 2001). However, these methods will lead to 
constitutive mutations, and are therefore incompatible with genes 
essential for cell growth, viability or pluripotency, as induction of the 
mutation will lead to death or differentiation of the mESCs. As Yap has 
been reported to be associated with cell proliferation (Zhao et al., 2007; 
2008) and in mESC self renewal (Lian et al., 2010; Tamm, Bower & 
Anneren, 2011), derivation of targeted mutant Yap cells using these 
strategies could be ineffective . 
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To circumvent the problem associated with direct mutation leading to cell 
death or differentiation, conditional mutagenesis using site-specific 
recombinases can be used (Gu, Zou & Rajewsky, 1993). The 
bacteriophage P1 Cre protein can catalyze recombination between loxP 
sites in mammalian cells (Sauer & Henderson, 1988). LoxP sites can be 
introduced on either side of an exon, and subsequent expression of Cre 
will lead to recombination and removal of the exon (Figure 5.2). This 
allows for derivation of cells that contain the conditional mutation in both 
alleles, such that only experimental expression of Cre will lead to a 
knockout.  
 
Figure 5.2. Excision of an exon via Cre-mediated recombination. Schematic 
illustrating Cre mediated recombination. In this example loxP sites (red 
triangles) flank exon 3. Expression of Cre recombinase results in site-specific 
recombination between loxP sites, leading to excision of exon3. 
Large-scale gene knockout consortia have been established, including 
the European Conditional Mouse Mutagenesis Program (EUCOMM) and 
the KnockOut Mouse Project (KOMP), with the aim of generating a 
comprehensive and public resource of heterozygous reporter tagged 
mESCs for each gene in the mouse genome (Ringwald et al., 2010). The 
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majority of these are generated using the “knockout-first” targeting 
strategy (Testa et al., 2004). In this strategy, a targeting vector introduces 
loxP sites either side of a critical exon, together with a selection cassette, 
which contains neomycin resistance and a β-galactosidase reporter gene. 
FRT sites either side of the selection cassette allow for its removal by 
expression of the recombinase, Flipase (Flp). Removal of the selection 
cassette will result in the formation of a conditional allele (Figure 5.3). A 
splice acceptor in the selection cassette, and a subsequent 
polyadenylation signal terminates the endogenous mRNA transcript such 
that the gene is not transcribed downstream of the cassette site, creating 
a knockout allele (Testa et al., 2004).  
 
Figure 5.3. ‘Knockout-first’ targeting approach. Schematic illustrating 
knockout-first targeting. The targeting vector inserts a LacZ reporter and 
neomycin selectable marker flanked by FRT sites (green triangles), whilst also 
introducing loxP sites either side of a critical exon. SA=splice acceptor, 
pA=polyadenylation sequence. 
Tate et al. have described a serial targeting strategy for the generation of 
homozygous conditional mutations, which takes advantage of the readily 
available EUCOMM/KOMP targeting vectors and targeted mESC clones 
(Figure 5.4) (Tate & Skarnes, 2011). The first step in this strategy 
consists of transiently exposing the heterozygous “knockout-first” clones 
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to Flp recombinase to generate a conditional allele. In the second step, 
the remaining wild-type allele can then be targeted using the targeting 
vector that was used to create the Yap knockout-first allele. In the third 
step subsequent targeting of a tamoxifen-responsive Cre recombinase to 
the Rosa26 locus can create inducible Cre expression (Vooijs, Jonkers & 
Berns, 2001; Indra et al., 1999). Ultimately, the addition of tamoxifen will 
induce loxP recombination in the conditional and knockout first alleles, 
resulting in gene deletion. 
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Figure 5.4. Serial targeting strategy Schematic illustrating serial targeting 
strategy. Step 1 involves transient expression of Flp recombinase to remove the 
selection cassette. Step 2 involves targeting the wild type Yap allele, using the 
KOMP knockout-first targeting vector. Step 3 involves targeting CreERT2 into 
the ROSA26 locus. Step 4 is addition of tamoxifen (+4OHT) to induce Cre-
mediated recombination and generation of a Yap knockout. Names of Cell lines 
and Clones derived from each step are indicated on the right. 
5.2 Serial	targeting	strategy		
A Yap targeted knockout-first mESC clone (YapE08) was acquired from 
KOMP. This was generated by KOMP through targeting of JM8 cells, a 
mESC cell line derived from C57BL/6N mice (Pettitt et al., 2009). The 
targeting vector inserted a knockout first trapping cassette into the 
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intronic region between exon 2 and exon 3 of the mouse Yap locus 
(Figure 5.5). KOMP supplied this clone with PCR confirmation of the 
correct targeting. The YapE08 cell line is heterozygous for Yap, shows no 
overt phenotype and can be cultured in standard mouse embryonic stem 
cell conditions with serum and LIF, with or without mouse embryonic 
fibroblasts. The splice acceptor in the LacZ portion of the cassette results 
in production of β-galactosidase driven by the endogenous Yap promoter. 
Histochemical staining with X-Gal confirmed that β-galactosidase is 
expressed in the YapE08 cell line, which implies the expression of Yap  
(Figure 5.5). 
 
Figure 5.5. YapE08 ‘knockout first’ targeted cell line. (A) Schematic 
illustrating the KOMP targeted knockout-first allele in YapE08. (B) Phase 
contrast image of YapE08 cells growing in culture. (C) X-gal staining of YapE08 
cells. Scale bars 200µm. 
In order to target the wild-type allele, the first step required removal of the 
selection cassette by transient expression of Flp recombinase. Creation 
of a conditional allele can be accomplished by removal of the selection 
cassette using Flp recombination (step 1 in Figure 5.4). The pCAGGS-
FlpE-Puro plasmid (Beard et al., 2006) was used to transiently express 
Flp recombinase in YapE08 cells. Digestion of the pCAGGS-FlpE-Puro 
plasmid with EcoR1 resulted in the expected band sizes of 7kb and 0.5kb, 
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confirming that the plasmid contained Flp recombinase (Figure 5.6). The 
circular plasmid was electroporated into YapE08 cells, and subsequently 
selected for with puromycin for 2 days to eliminate cells that did not take 
up the plasmid. As Flp-induced recombination of the selection cassette 
would also remove the LacZ reporter, subsequent clones were screened 
for loss of β-galactosidase by histochemical staining with X-Gal (Figure 
5.7A). 21 clones were obtained following electroporation with pCAGGS-
Flp-Puro and selection with puromycin. Of these 21 clones, 13 had lost 
expression of β-galactosidase, 5 had retained expression and 3 had 
failed to proliferate (Figure 5.7B). This represents 62% efficiency for Flp 
recombination of the selection cassette under these electroporation and 
selection conditions.  
 
Figure 5.6. Restriction digest of pCAGGS-Flpe-Puro. pCAGGS-FlepE-Puro 
plasmid digest with EcoRI. Expected band sizes 7kb and 0.5kb 
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Figure 5.7. Screening for loss of LacZ in Flp-treated ES cell clones. (A) X-
gal staining of 21 expanded clones after transient transfection of Yap knockout-
first cells with pCAGGS-FlpE-Puro. (B) Table indicates proportion of cells 
positive or negative for X-gal stain. Failed indicates clones that did not 
proliferate in culture. 
The presence of any remaining selective resistance gene would hinder 
further targeting. Flp recombination should have led to excision of the 
Neo selection marker, while puromycin resistance from the pCAGGS-Flp-
Puro plasmid should not have been integrated. The resulting clones were 
therefore screened for sensitivity to puromycin and G418 (Figure 5.8). 
Clones were expanded in triplicate and cultured in standard culture media 
or in the presence of 1µg/ml puromycin or 150µg/ml G418. Of the 21 
clones, only one displayed resistance to puromycin and all 21 clones 
were sensitive to G418. As clone 11 had lost expression of β-
galactosidase, and was sensitive to both G418 and puromycin, this 
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indicated that Flp recombination had possibly occurred. Clone 11 was 
therefore selected as suitable for subsequent targeting steps. 
 
Figure 5.8. Screening for antibiotic resistance in Flp-treated ES cell clones. 
(A) Phase contrast images of expanded Flp treated clones, in the conditions 
indicated. Clone numbers 1 and 11 are shown. Note presence of cells growing 
in puromycin in clone 11. (B) Table indication Total number of clones sensitive 
to Puromycin and G418. 
 
In order to target the second allele (step 2 in Figure 5.4), the Yap 
targeting vector used in the creation of YapE08 was acquired from KOMP 
(Figure 5.9A). Digestion of the Yap targeting plasmid with FspI or PvuII 
resulted in the expected band sizes, confirming that the plasmid 
contained the Yap targeting vector (Figure 5.9B). The targeting vector 
was linearized by a restriction digest at a unique restriction site with AsiSI 
(Figure 5.9C). The linearized targeting vector was electroporated into 
clone 11 and subsequently selected for with G418. 96 clones were 
derived after selection with G418. 
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Figure 5.9. Restriction digests of the Yap targeting vector (A) Schematic of 
Yap targeting vector. (B) Restriction digest of Yap targeting vector with FspI or 
PvuII. (C) Expected band sizes in kb of restriction digest in A. (D) Linearization 
of Yap targeting vector with AsISI. 
  
The 96 clones were then screened for the expression of LacZ as an 
indicator of the correct targeting event. As this targeting vector re-
introduces the LacZ reporter into the Yap locus, and Yap is expressed in 
mESCs, correct targeting should result in expression of β-galactosidase 
from the endogenous Yap promoter. Histochemical staining of the 96 
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clones with X-Gal revealed 12 clones expressing β-galactosidase (Figure 
5.10). This narrows down screening of these 12 clones for correct 
targeting.  
 
Figure 5.10. Screening for expression of LacZ in Yap-targeted ES cell 
clones. (A) X-gal staining of 96clones in a 96-well plate. (B)Table indicates 
proportion of cells positive or negataive for X-gal. Failed indicates clones that 
did not proliferate in culture. 
Detection of bi-allelic targeting was screened for using long-range PCR 
(Figure 5.11). Clones with targeted mutations in both alleles will have one 
conditional allele and one knockout-first allele. The presence of the 
knockout-first allele can be detected using Yap gene-specific primers in 
combination with vector-specific primers to the splice acceptor and neo 
gene (termed GF+EN2R and NF+GR respectively). This will also confirm 
target vector integration at the correct locus, as opposed to random 
vector integration (Figure 5.11). Presence of the conditional allele can be 
detected using primers directed to the upstream 5’ Yap locus and the 
distal loxP site in the targeting vector (GF+LR) (Figure 5.11). As the 
knockout-first allele is approximately 5kb larger than the conditional allele, 
it is too large to be amplified by the primer pair GF+LR in this protocol. 
The 12 clones that were positive for β-galactosidase expression were 
screened for the presence of bi-allelic targeting using this long range 
PCR strategy. Clone number 11:26 was found to be positive for both the 
conditional allele and the knockout-first allele (Figure 5.11). Clone 11:26 
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was therefore selected for subsequent targeting of Cre-ERT2 to the 
ROSA26 locus. 
 
Figure 5.11. Screening for bi-allelic targeted clones by long-range PCR. (A) 
Schematic illustrating primer locations. (B) Long-Rage PCR of Yap targeted 
clones. Primer pairs GF+En2R and NF+GR detect presence of the targeting 
cassette in the knockout-first allele. Primer pair GF+LR detects presence of the 
conditional allele. Expected band sizes for each primer pair are shown. * 
indicates that clone 11:26 has expected bands for each primer pair, implying the 
presence of both knockout-first and conditional alleles.  
Targeting of the tamoxifen responsive Cre-ERT2 gene to the ROSA26 
locus (step 3 in Figure 5.4) will provide a system for temporal regulation 
of Cre recombination. The PMB80 (Ventura et al., 2007) plasmid was 
used to introduce Cre-ERT2 into the ROSA26 locus. Digestion of the 
pMB80 plasmid with XBaI confirmed  (Figure 5.12). The targeting vector 
was linearized by restriction digest at a unique restriction site with AscI. 
The linearized targeting vector was electroporated into clone 11:26 and 
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subsequently selected for with puromycin. 36 clones were obtained 
following selection with puromycin.  
 
Figure 5.12. Restriction digest of pMB80 with XbaI. Restriction digest of 
pMB80 with XbaI, expected band sizes 10kb and 4kb.  
As targeting of Cre-ERT2 to the ROSA26 locus is highly efficient (Vooijs, 
Jonkers & Berns, 2001), the 36 clones were screened for tamoxifen 
responsive Cre activity. Clones were expanded in duplicate, and cultured 
in standard culture medium with or without tamoxifen for 24hours. 
Tamoxifen induced Cre recombination was screened for using PCR 
(Figure 5.13). Primers were designed either side of the floxed exon which 
would give a PCR product of 1.1kb (CritF+CritR Figure 5.13A). Cre 
recombination would lead to excision of the exon thus resulting in a 
smaller PCR product of 280bp. The presence of the smaller PCR product 
upon addition of tamoxifen would therefore indicate inducible Cre 
recombination. From the 36 clones only clone 11:26:9 was found to 
exhibit the shortened PCR product upon addition of tamoxifen and 
therefore was assumed to have inducible Cre activity (Figure 5.13B,C). 
As clone 11:26 contained a conditional and knockout-first allele, Cre 
recombination induced by tamoxifen in clone 11:26:9 should result in 
knockout alleles.  
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Figure 5.13. Screening for tamoxifen responsive Cre activity in 
ROSA26:Cre-ERT2 clones. (A) Schematic illustrating location of CritF and CritR 
primers. (B) PCR analysis of clones 11:26:7, 11:26:8 and 11:26:9 with 
CritF+CritR primer pair. Cells were treated with or without tamoxifen (+4OHT), 
indicated by + or – respectively. Expected band sizs are 1.1kb for the conditional 
allele and 280bp for the deletion allele. As PCR amplification failed in the –
Tamoxifen control of 11:26:9, PCR analysis was repeated in (C) repeat PCR of 
clone 11:26:9  
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In order to check that Cre recombination was leading to loss of Yap 
exon3, a primer was designed to inside exon 3 (Ex3F, Figure 5.14A). 
PCR amplification using the primer pair Ex3F+CritR would result in a 
product of 400bp. Upon tamoxifen induced Cre recombination, this exon 
should be recombined out, thus no PCR product should be obtained. 
Clone 11:26:9 was expanded in duplicate and cultured in standard culture 
medium with or without tamoxifen for 24 hours. A PCR product of the 
expected size was amplified from cells following addition of tamoxifen 
(Figure 5.14B), suggesting that complete recombination of exon3 had not 
occurred.  
 
Figure 5.14. Yap exon 3 is not excised following addition of tamoxifen (A) 
Schematic illustrating location of Ex3F and CritR primers. Note that upon Cre-
mediated recombination Ex3F primer site should be removed. (B) PCR analysis 
of clone 11:26:9 with Ex3F+CritR primer pair. Cells were treated with or without 
tamoxifen (+4OHT) for 24hours. Expected band size 400bp. 
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Deletion of Yap exon 3 is predicted by KOMP to result in a frame shift, 
leading to nonsense-mediated decay of the mRNA. RT-PCR was 
therefore performed to assess if there was a reduction in Yap mRNA 
levels following addition of tamoxifen to clone 11:26:9. Clone 11:26:9 was 
expanded in duplicate and cultured in standard culture medium with or 
without tamoxifen for 24 hours, and then RT-PCR was performed. No 
difference was observed in Yap mRNA levels following addition of 
tamoxifen (Figure 5.15A). To assess if addition of tamoxifen had any 
effect on Yap protein expression, Clone 11:26:9 was expanded in 
duplicate and cultured in standard culture medium with or without 
tamoxifen for 48 hours and then immunostained for Yap (Figure 5.15B). 
No loss of Yap protein was observed by immunofluorescence was 
observed following addition of tamoxifen. This suggests that addition of 
tamoxifen is not leading to knockout alleles of Yap in this clone. 
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Figure 5.15. Treatment with tamoxifen does not lead to loss of Yap mRNA 
or Protein expression in clone 11:26:9. (A) Clone 11:26:9 was treated with or 
without tamoxifen for 24 hours and RT-PCR was performed. Beta-Actin was 
used as a loading control. (B) Representative confocal images of clone 11:26:9 
stained for Hoechst (blue), Yap (green), grown in S+L (left panels) or treated 
with tamoxifen for 48h (right panels). Scale bar: 50µm. 
In order to ascertain why clone 11:26:9 did not behave as expected upon 
tamoxifen treatment, a more detailed PCR analysis of clone 11:26:9 and 
its parental clones was undertaken. Using the CrtiF and CritR primers the 
expected amplified PCR product from clone 11:26:9 would be 1.1kb. 
However, this PCR resulted in two bands, one of the expected size of 
1.1kb and another smaller 900kb band (Figure 5.16A). The same two 
bands were seen in clone 11:26. Clone 11 contains a conditional allele 
and a wild-type allele (Figure 5.4). As the CritF and CritR primer pair will 
also amplify the wild-type allele, two bands of sizes 1.1kb and 900kb are 
expected. This therefore suggests that the 900kb band is from the wild-
type Yap allele. This was confirmed by PCR amplification of YapE08 
using the CritF and CritR primer pair (Figure 5.16B). As YapE08 does not 
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contain a conditional allele, but does contain a wild-type allele, only one 
band of 900kb is expected. 
As targeting of the second allele in clone 11:26 should eliminate the wild-
type allele, the wild-type allele should not be present in clone 11:26:9. 
This suggests that clone 11:26 was clonally impure and contained a 
mixed population of cells: some cells with the correct targeted allele 
(labelled as clone 11:26, Figure 5.4) and some cells remaining from the 
previous step in the cloning strategy i.e. clone 11. This mixed population 
of clone 11:26 and clone 11 cells could explain the presence of the wild-
type band. Indeed, addition of G418 to the culture medium led to 
widespread cell death in cultured clones 11:26 and 11:26:9 indicating that 




Figure 5.16. PCR analysis reveals wild-type allele in clones 11:26 and 
11:26:9 (A) PCR analysis of clones 11, 11:26:8 and 11:26:9 with CritF+CritR 
primer pair. Expected band sizs are 1.1kb for the conditional allele and 900bp 
for the wild-type allele. (B) PCR analysis of clone 11:26:9 with and without 
tamoxifen treatment and YapE08 with CritF+CritR primer pair. Expected band 
sizes are 1.1kb for the conditional allele, 900bp for the wild-type allele and280bp 
for the deletion allele 
5.3 Summary	
A serial targeting strategy was implemented with the aim of creating an 
inducible Yap knockout mESC line. This line would then be used to 
assess the role of Yap in the processes of self-renewal and differentiation. 
While the serial targeting strategy initially appeared to be successful, 
further investigation revealed that resulting cell line did not induce 
knockout alleles of Yap and was clonally impure. 
5.4 Discussion	
Creation of an inducible knock out of Yap in mESCs would provide an 
experimental model in which to assess the role of Yap in the processes of 
self-renewal and differentiation. In order to achieve this, both alleles of 
Yap must be targeted. The serial targeting strategy as described by Tate 
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et al. requires multiple rounds of targeting and selection, which introduces 
multiple possibilities for error. PCR analysis appears to show that 
isolation of clone 11:26 resulted in contamination with cells carrying a 
wild-type allele from the previous step in the strategy. At this step, only 
long range PCR was used to screen for presence of conditional and 
knockout alleles. The primers used in this screening would not detect the 
presence of wild-type allele, as they were designed on parts of the 
targeting vector, and as these cells had survived selection, and were 
picked as individual colonies, clonality was assumed. However, it is 
possible that contamination with incorrectly targeted cells occurred during 
high throughput expansion of clones in 96 well plates. In hindsight, further 
checks should have been made in regards to the identity of clone 11:26, 
such as checking for resistance to G418 before proceeding with the 
targeting protocol. 
A mixed population of cells in this case would be especially detrimental 
due to the phenomenon of cell competition, in which ‘fitter’ cells 
outcompete ‘less fit’ cells (Amoyel & Bach, 2014). The Drosophila 
homologue of Yap, Yorkie (Yki) has been shown to be involved in cell 
competition, such that cells with higher levels of Yki are able to 
outcompete wild-type cells (Ziosi et al., 2010; Neto-Silva, de Beco & 
Johnston, 2010). More recently, Tead transcription factors have been 
shown to be involved in cell competition with increased Tead 
transcriptional activity leading to increased cell fitness in mouse 
embryonic fibroblasts (Mamada et al., 2015). This would suggest that 
cells homozygous for Yap would have a competitive advantage over cells 
that are heterozygous. Thus, contamination of clone 11:26 with cells that 
are potentially homozygous for Yap (as evidenced by presence of a wild-
type allele) would lead to the contaminating cells outcompeting and 
overrunning the culture. This could explain why clones 11:26 and 11:26:9 
were so sensitive to G418. 
Since beginning this work using this serial targeting strategy, which relies 
on random homologous recombination, numerous technologies for 
introducing targeted mutations have been described. Zinc finger 
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nucleases, Transcription Activator-Like Nucleases (TALENs) and 
CRISPR-Cas9 systems can be designed to induce targeted double strand 
breaks, which then introduce mutations through endogenous repair 
pathways (reviewed in Gaj, Gersbach & Barbas, 2013). Non Homologous 
End Joining (NHEJ) repairs double strand breaks through direct ligation. 
NHEJ is an error prone process, which can result in insertions or 
deletions at the target site, which leads to frame shift mutations, thus 
impairing gene function(reviewed in Gaj, Gersbach & Barbas, 2013). 
Alternatively, template DNA can be provided, and Homology Directed 
Repair (HDR) will use the template DNA to repair the double strand break 
thus incorporating a desired mutation(reviewed in Gaj, Gersbach & 
Barbas, 2013). However, despite their increased efficiency compared to 
homologous recombination, zinc finger nucleases and TALEN systems 
have been expensive (reviewed in Gaj, Gersbach & Barbas, 2013). More 
recently, the CRISPR-Cas9 system has emerged as a low cost, simple, 
high efficiency method for genome editing (reviewed in Ran et al., 2013). 
The use of targeted double strand breaks would allow mutations to be 
introduced more efficiently, therefore reducing the large amount of 
screening as required with random homologous recombination 
techniques (reviewed in Ran et al., 2013).  
The serial targeting strategy was implemented in order to create an 
inducible mutant of Yap, due to potential cell death or differentiation upon 
knockout of Yap. However, recently it has been shown that depletion of 
Yap and Taz by siRNA is inconsequential for mESC propagation in 2i 
culture (Azzolin et al., 2014). This observation suggests that Yap is not 
required for growth or maintenance of self-renewal in mESCs under 2i 
conditions. Therefore, a conditional approach may not be required for the 
creation of Yap knockout mESCs. The CRISPR-Cas9 system could be 
used as an efficient, cost effective method to create a constitutive 










In this work I have examined Yap in the context of differentiation and cell 
fate choice, focusing mainly on differentiation towards primitive endoderm 
(PrE). In Chapter 3: I show that upon initial differentiation of mouse 
embryonic stem cells (mESCs), nuclear Yap expression increases.  
Furthermore, in an in vitro model of PrE differentiation, I show that 
increased nuclear Yap expression is associated with differentiation 
towards PrE-like cells, as opposed to epiblast-like cells. Furthermore I 
show that the increase in nuclear Yap expression does not appear to be a 
result of reduced phosphorylation of Yap at S112. Subsequently I show 
that cytoplasmic retention of Yap using dobutamine results in decreased 
differentiation towards PrE. 
In Chapter 4:  I examine Yap in the corresponding differentiation event in 
the mouse pre-implantation embryo. I show that increased nuclear Yap 
expression is associated with increased Gata6 expression in PrE cells, 
during both specification and eventual sorting. As in mESCs, this 
increase in nuclear Yap expression did not appear to be a result of 
reduced phosphorylation of Yap at S112. Cytoplasmic retention of Yap in 
embryos using dobutamine resulted in decreased markers of both PrE 
and Epi fates.  
Finally in Chapter 5:  I attempt to create an inducible knockout of Yap, 
with the intention to assess the requirement of Yap in self-renewal of 
mESCs. Unfortunately, although the serial targeting strategy initially 
appeared to be successful, subsequent analysis found the resulting cell 
line was not inducing knockout alleles of Yap and was most likely clonally 
impure.   
6.2 Yap	in	PrE	cell	fate	specification	
As increased nuclear Yap expression was associated with differentiation 
towards PrE both in vitro and in vivo, this may suggest that Yap is 
involved in the specification of PrE. As Yap is important in the previous 
cell fate specification of the trophectoderm (TE) (Nishioka et al., 2009), 
this could suggest that Yap is part of a conserved mechanism for cell-fate 
 117 
specification. However, whereas specification of the TE involves position-
dependent inhibition of Hippo signalling, specification of PrE and Epi 
precursors occurs throughout the inner cell mass (ICM) apparently 
independent of position (Nishioka et al., 2009; Chazaud et al., 2006; 
Plusa et al., 2008). Yet one of the remarkable aspects of Hippo signalling 
is the diverse array of upstream inputs, including cell-cell junctions, 
polarity, mechanical cues, cellular stress, extracellular signals and cross 
talk with other signalling pathways (reviewed in Yu, Zhao & Guan, 2015). 
Perhaps in the specification of PrE, Hippo signalling is initially regulated 
by another input other than polarity. One example could be Fgf signalling, 
which is instrumental in the this cell fate specification through up-
regulation of Gata6 and down-regulation of Nanog (Chazaud et al., 2006; 
Kang et al., 2012; Yamanaka, Lanner & Rossant, 2010; Nichols et al., 
2009; Bessonnard et al., 2014). Expression of constitutively active Ras, a 
downstream component of Fgf signalling, has been reported to increase 
nuclear Yap expression in mammalian cells (Reddy & Irvine, 2013). 
Furthermore siRNA knock-down of Tead4 in cells of the ICM leads to 
reduced expression of the Fgf receptor (Fgfr2), perhaps suggesting that 
Fgfr2 is a target of Yap-Tead4 co-activation (Mihajlović, Thamodaran & 
Bruce, 2015). Yap may therefore have a role in reinforcing PrE cell fate 
specification downstream of Fgf signalling, forming a positive feedback 
loop whereby activation of Fgf signalling may lead to increased nuclear 
Yap expression, resulting in increased expression of Fgfr2 (Figure 6.1). 
Another potential input into the Hippo signalling pathway during the 
specification of PrE is LIF signalling. In mESCs, LIF binds to a 
heterodimeric receptor composed of glycoprotein 130 (gp130), resulting 
in activation of Janus associated tyrosine kinases (JAK) that 
phosphorylates signal transducer and activation of transcription 3 
(STAT3) (reviewed in Hirai, Karian & Kikyo, 2011). LIF activation of 
STAT3 subsequently results in the up regulation of pluripotency markers 
(Hall et al., 2009). However recent studies have reported a role that LIF 
also supports extraembryonic gene expression in mESC culture and 
furthermore, treatment of pre-implantation embryos with LIF results in an 
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increased proportion of PrE cells (Morgani et al., 2013; Morgani & 
Brickman, 2015). Interestingly, LIF has also been shown to activate the 
Src family kinase Yes, resulting in a subsequent tyrosine phosphorylation 
of Yap in mESCs (Tamm, Bower & Anneren, 2011). This tyrosine 
phosphorylation of Yap leads to increased Tead2 dependent transcription 
(Tamm, Bower & Anneren, 2011). It is therefore possible that Yap acts 
downstream of LIF leading to increased extraembryonic gene expression 
thereby supporting speciation of PrE. 
In specification of the TE, Yap co-activates Tead4 transcription of Cdx2 
and Gata3, two TE specific transcription factors (Nishioka et al., 2009; 
Ralston et al., 2010). It would be interesting to investigate transcriptional 
targets of Yap in PrE cells to examine if Yap leads to increased 
expression of PrE specific factors such as Gata6. Interestingly, a recent 
study has shown that in embryonic pancreatic progenitor cells, Yap, Tead 
and Gata6 bind to enhancers of genes associated with pancreatic 
development, notably Hhex and Fgfr2 (Cebola et al., 2015). Hhex and 
Fgfr2 are associated with PrE development (Thomas, Brown & 
Beddington, 1998; Arman et al., 1998), which suggests the possibility that 
during differentiation, Yap acts with Gata6 to enhance transcription of 
endodermal associated targets.  
In the specification of the TE, Hippo signalling is inhibited in outer, 
polarized cells, thus allowing Yap to act as a transcriptional co-activator 
leading to increased expression of TE specific transcription factors such 
as Cdx2 (Nishioka et al., 2009; Hirate et al., 2013). Inner, apolar, cells 
have increased cell-cell contacts resulting in activation of Hippo signalling, 
which results in cytoplasmic Yap and specification of the ICM (Nishioka et 
al., 2009; Hirate et al., 2013). Subsequently specification of PrE and Epi 
precursors occurs in cells of the ICM independently of positional 
information (Chazaud et al., 2006; Plusa et al., 2008). Perhaps increased 
stability of Yap downstream of Fgf and Lif signalling provides a 
mechanism for Yap to overcome Hippo mediated cytoplasmic retention, 
thus allowing Yap to translocate to the nucleus and support the 
expression of genes associated with PrE (Figure 6.1). Furthermore, 
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overexpression of Nanog has been reported to reduce Tead2 dependent 
transcriptional activity in mESCs (Tamm, Bower & Anneren, 2011), which 
could indicate a mechanism for Nanog to prevent Yap dependent 
expression of PrE associated genes in Epi precursors. This could 
therefore represent possible mechanisms of Hippo signalling in the 
specification of Pre and Epi. 
 
Figure 6.1. Possible regulation of Yap by Hippo, Fgf and LIF signalling 
pathways in specification of PrE. Hippo signalling member Lats can 
phosphorylate Yap resulting in cytoplasmic retention. Fgf signalling through Ras 
may lead to increased nuclear Yap expression, resulting in expression of Fgf 
receptor (Fgfr) forming a positive feedback loop. LIF signalling can activate Yes 
kinase, leading to phosphorylation and subsequent increased transcriptional 
activity of Yap. 
 
6.3 Yap	and	the	Hippo	signalling	pathway	in	cell	fate	decisions	
The specification of TE and PrE, are binary fate decisions, such that a 
precursor cell differentiates into one of two available fates, i.e. TE or ICM, 
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PrE or Epi. Yap has been reported to be involved in a number of binary 
cell fate decisions. In zebrafish eye development, optic vesicle 
progenitors will differentiate into either neural retina or retinal pigment 
epithelium (RPE) (reviewed in Fuhrmann, Zou & Levine, 2014). Yap has 
been shown to be required for in this cell fate specification such that Yap 
mutants cannot form RPE (Miesfeld et al., 2015). Furthermore, in the 
Drosophila visual system, bi-potent R8 photoreceptor neurons 
differentiate into one of two alternative photoreceptor subtypes, 
expressing either blue light sensitive Rhodopsin5 (Rh5) or green light 
sensitive Rhodopsin6 (Rh6). Yorkie (Yki), the Drosophila homolog of Yap, 
is reported to be central in a positive feedback network, which promotes 
differentiation of the Rh5 subtype (Jukam et al., 2013). Yap and the Hippo 
pathway could therefore represent a common mechanism of integrating 
multiple upstream signals in specification of cell fates.  
6.4 Future	directions	
Is	Yap	absolutely	required	for	PrE	cell	fate	specification?	
I have shown that increased nuclear Yap expression is associated with 
PrE specification, and that inhibition of Yap with dobutamine can 
decrease differentiation towards PrE cell fate. However studies of Yap 
knockout cell lines and embryos would identify if there is an absolute 
requirement of Yap in PrE cell fate. Crispr genome editing could be used 
to create a knockout of Yap in the Gata6-inducible mESC line. If Yap is 
absolutely required for differentiation towards PrE, induction of Gata6 
would no longer result in PrE differentiation. Furthermore analysis of 
markers of PrE in Yap-/- mouse embryos could provide insight into the 
requirement for Yap in specification and differentiation of the PrE. 
What	are	the	transcriptional	targets	of	Yap	in	PrE	differentiation?	
If Yap is associated with PrE cell fate specification, how does it mediate 
this effect? Differentiation towards PrE could be induced by 
overexpression of Gata6 in mESCs and Chromatin immunoprecpitation 
and gene expression microarray analysis could identify transcriptional 
targets of Yap.  
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Is	Yap	required	for	self-renewal	of	mESCs?		
Yap is believed to have a critical role in the maintenance of self-renewal 
and pluripotency in mESCs. Unfortunately my attempt at creating an 
inducible knockout of Yap using a serial targeting strategy was 
unsuccessful. However the CRISPR-Cas9 system represents an efficient, 
cost effective method to create a constitutive knockout in order to study 
the role of Yap in mESC self renewal and differentiation. 
Is	Yap	stability	affected	by	Fgf	signalling	in	mESCs?	
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